Text

Offsite Dose Calculation Manual
	ML19305B803
Person / Time
Site:	McGuire, Mcguire
Issue date:	03/17/1980
From:	; DUKE POWER CO.
To:	;
Shared Package
ML19305B799	List: ML19305B798; ML19305B803;
References
	NUDOCS 8003200403
	Download: ML19305B803 (100)
	v • d • e

.

U i

}

OFFSITE DOSE CALCULATION MAyggt FOR D M POWER NUCLEAR STATIONS 1

8003200 h O3

TABLE OF CONTENTS SECTION Page INTRODUCTION iii i

1.0 RELEASE RATE CALCULATIONS 1-1 1.1 LIQUID EFFLUENTS 1-1 1.2 GASEOUS EFFLUENTS 1-1 1.2.1 Noble Gases 1-1 1.2.2 Radioiodines, Particulates, and Others 1-2 2.0 RADIATION MONITORING SETPOINTS 2-1 2.1 LIQUID MONITORS 2-1 2.2 GAS MONITORS 2-1 3.0 DOSE CALCULATIONS 3-1 3.1 DOSE MODELS FOR MAXIMUM EXPOSED INDIVIDUAL 3-1 3.1.1 Liquid Effluent 3-1 3.1.2 Gaseous Effluents 3-2 3.1.2.1 Noble Gases 3-2 3.1.2.2 Radioiodines, Particulates, and Others 3-3 3.1.3 Direct Radiation 3-7 3.2 SIMPLIFIED DOSE ESTIMATES 3-7 3.3 FUEL CYCLE CALCULATIONS 3-8 3.3.1 Milling 3-8 3.3.2 Conversion 3-8 3.3.3 Enrichment 3-8 3.3.4 Fuel Fabrication 3-8 3.3.5 Nuclear Power Production 3-9 1

3.3.6 Fuel Reprocessing 3-9 3.4 POPULATION DOSES 3-9 3.4.1 Liquid Effluents 3-9 3.4.2 Gaseous Effluents 3-11 3.4.2.1 Noble Gases 3-11 3.4.2.2 Radioiodines, Particulates, and Others 3-11 3.4.3 Direct Radiation 3-16 i

Appendix A Oconee Nuclear Station Site Specific Infermation Appendix B - McGuire Nuclear Station Site Specific Information Appendix C - Catawba Nuclear Station (Later)

Site Specific Information

LIST OF TABLES Table 1.2-1 Dose Factors for Noble Gases and Daughters Table 1.2-2 Dose Parameters for Radioiodines and Radioactive Particulate, Gaseous Effluents Table 3.1-1 Bioaccumulation Factors to be Used in the Absence of Site Specific Data Table 3.1-2 Ingestion Dose Factors for Adults

-Table 3.1-3 Ingestion Dose Factors for Teenager Table 3.1-4 Ingestion Dose Factors for Child Table 3.1-5 Ingestion Dose Factors for Infant Table 3.1-6 Inhalation Dose Factors for Adults Table 3.1-7 Inhalation Dose Factors for Teenager Table 3.1-8 Inhalation Dose Factors for Child Table 3.1-9 Inhalation Dose Factors for Infant Table 3.1-10 External Dose Factors for Standing on Contaminated Ground Table 3.1-11 Stable Element Transfer Data ii a

-a

INTRODUCTION The Offsite Dose Calculation Manual provides the methodology and parameters to be used in the calculation of off-site doses due to radioactive liquid and gaseous effluents to assure compliance with the dose limitations of the Technical Specifications. These dose limitations assure that:

1) the concentration of radioactive liquid ef fluents from the site to the unrestricted area will be limited to the concentration levels of 10CFR20, Appendix B, Table II; 2) the exposures to any individual from radioactive liquid effluents will not result in doses greater than the design objectives of 10CFR50, Appendix I; 3) the dose rate at any time at the site boundary from radioactive gaseous effluents will be limited to the annual dose limits of 10CFR20 for unrestricted areas; and 4) the exposure to any individual from radioactive gaseous effluents will not result in doses greater than the design objectives of 10CFR50, Appendix I.

The methodology used to assure compliance with the dose limitations described above shall also be used to prepare the radioactive liquid and gaseous effluent reports required by the Technical Specif~ cations. To assure compliance with 40CER190 when twice the design objectives of 10CFR50, Appendix I are exceeded, the methodology and parameters to be used in calculating the off-site dose to any individual resulting from the entire fuel cycle except mining and waste management facilities are provided in this Manual.

The Manual also provides the methodology and parameters to be used in the calculation of radioactive liquid and gaseous effluent monitoring instrumen-tation alarm / trip setpoints to assure compliance with the concentration and dose rate limitations of the Technical Specifications.

Changes to the methodology and parameters used in this Manual shall be reviewed by a qualified reviewer (s) and approved by the Station Manager and Nuclear Safety Review Board prior to implementation. Changes to this Manual shall be submitted to the Nuclear Regulatory Commission within 90 days of the date the change was made effective by inclusion in the Monthly Operating Report to comply with the Technical Specifications.

This Manual does not replace any statlan implementing procedures.

iii

1.0 RELEASE RATE CALCULATIONS The release rate calculations presented in the following sections are site release limits. Sites containing two or more units shall administratively control releases to assure that the release rate calculations limit releases as stated in the Technical Specifications. Administrative controls could limit the number of releases occurring at one time or apportion the release rate between the units.

1.1 LIQUID EFFLUENTS To comply with Technical Specifications and to assure that the concentration of radioactive liquid effluents from the site to the unrestricted area is limited to the concentrations of 10CFR20, Appendix B, Table II, Column 2, the following release rate calculation shall be performed:

n f $ F + (o I Ci )

i=1 MPC.

I where:

C

= The concentration of radionuclide, 'i', in undiluted liquid effluent, g

in pCi/ml.

MPC. = the concentration of radionuclide, 'i', from 10CFR20, Appendix B, Table II, Column 2, in pCi/ml.

f

= the undiluted effluent flow from the tank, in gpm.

F

= the dilution flow from the site discharge structure to unrestricted area receiving waters, in gpm.

1 a

= recirculation factor at equilibrium.

1.2 GASEOUS EFFLUENTS In order to comply with the Technical Specifications and to assure that the dose rate, at any time, in the unrestricted area due to radioactive materials released in gaseous effluents from the site is limited to 1500 mrem /yr to the total body and $3000 mrem /yr.to the skin for the noble gases and is limited to $1500 mrem /yr to any organ for all radiciodine and for all radioactive materials in particulates form and radionuclides other than noble gases with half lives greater than 8 days, the following release rate calculations shall be performed. These calculations, when solved for ' f', i.e.

flowrate, are the release rates for noble gases and for radioiodines, particulates and other radionuclides with half-lives greater than 8 days. The most conservative of release rates calculated shall control the release rate.

1.2.1 Noble Gases IK x [(X/Q)Q ]

<500 mrem /yr, and g

1 1

1-1 l.

g + 1.1 M ) ((X/Q)Q ]

<3000 mrem /yr I (L g

g 1

where:

K.

= The total body dose factor due to gamma emissions for each identified 3 from Table 1.2-1.

noble gas radionuclide, in mrem /yr per pCi/m L.

= The skin dose factor due to beta emissions for each identified noble 3

gas radionuclide, in mrem /yr per pCi/m from Table 1.2-1.

M.

= The air dose factor due to gamma emissions for each identified noole 3

gas radionuclide, in mrad /yr per pCi/m from Table 1.2-1 (unit con-version constant of 1.1 mrem / mrad converts air dose to skin dose).

P.

= The dose parameter for radionuclides other than noble gases for c.he 1

3 inhalation pathway, in mrem /yr per pCi/m and for the food and ground 2

plane pathways in m (mrem /yr) per pCi/see from Table 1.2-2.

The dose factors are based on the critical individual organ and most restric-tive age group (child or infant),

s Q

= The release rate of radionuclides, 'i', in gaseous effluent from all 1

release t.nts at the site, in pCi/sec.

(X/Q)= The highest calculated annual average dispersion parameter for any area at or beyond the unrestricted area boundary.

W

= The highest calculated annual average dispersion parameter for estimating the dose to an individual at the controlling location.

s Q.

= k C.f + k2 = 4.72E+2C.f t

i 1

1 where:

C. = the concentration of radionuclide, 'i', in undiluted gaseous effluent, in pCi/ml.

f =

the undiluted effluent flow, in cfm.

t conversion factor, 2.83E4 ml/ft3 k =

k2 = conversion factor, 6El sec/ min.

1.2.2 Radioiodines, Particulates, and Others s

IPg [W Q ] < 1500 mrem /yr 1

where the terms are as defined above.

1-2

TABLE 1.2-1 (1 of 1)

DOSE FACTORS FOR NOBLE GASES AND DAUGitTERS*

Total Body Gamma Air Beta Air Dose Factor Skin Dose Factor Dose Factor Dose Factor K.

L.

M.

N.

kadionuclide (mrem /yr per pCi/m )

(mrem /yr per pCi/m )

(mrad /yr pEr pCi/m )

(mrad /yr per pCi/m )

3 3

1.93E+01 2.66E+02 Kr-83m 7.56E-02**

Kr-85m 1.17E+03

!.46E+03 1.23E+03 1.97E+03 Kr-85 1.61Et01 1.34E+03 1.72E+01 1.95Et03 Kr-87 5.92E+03 9.73E+03 6.17Et03 1.03E+04 Kr-88 1.47E+04 2.37E+03 1.52E+04 2.93E+03 Kr-89 1.66Et04 1.01E+04 1.73E+04 1.06E+04 Kr-90 1.56E+04 7.29E+03 1.63E+04 7.83E+03 Xe-131m 9.15E+01 4.76E+02 1.56E+02 1.llE+03 Xe-133m 2.51E+02 9.94E+02 3.27E+02 1.48E+03 Ae-133 2.94E+02 3.06E+02 3.53E+02 1.05Et03 Xe-135m 3.12Et03 7.llE+02 3.36E+03 7.39E+02 Xe-135 1.81E+03 1.86E+03 1.92E+03 2.46E+03 Xe-137 1.42E+03 1.22E+04 1.51E+03 1.27E+04 Xe-138 8.83E+03 4.13E+03 9.21E+03 4.75E+03 Ar-41 8.84L+03 2.69E+03 9.30E+03 3.28E+03 TThe listed dose fact.or.; are for radionuclides that may be detected in gaseous ef fluents.

1'*7.56E-02 = 7.56 x 10 2,

TABLE 1.2-2 (1 of 1)

DOSE PARAMETERS FOR RADIOIODINES AND RADIOACTIVE PARTICULATE, GASEOUS EFFLUENTS

P(I), DOSE PARAMETERS FOR RADIOIODINES AND RADIOACTIVE PARTICULATES IN GASEOUS EFFLUENTS Pathways Pathways Inhalation Milk and Ground Inhalation Milk and Ground 2

2 (mrem /yr per m. nrem/yr per (mrem /yr per (m. mrem /yr per 3

a C.dionuclide pCi/m )

pCi/sec)

Radionuclide pCi/m )

pCi/sec) li 3**

6.5E+02 2.4E+03 RU 103 1.8E+04 1.6E+08 C 14**

2.6E+04 3.2E+06 RU 106 1.6E+05 3.0E+08 P 32 2.0E+06 1.6E+11 AG 110M 3.3E+04 1.5E+10 CR 51 3.6E+02 1.lE+07 CD 115M 7.0E+04 5.2E+07 MN 54 2.5E+04 1.1E+09 SN 123 2.9E+05 3.7E+09 FE 55 2.0Et04 1.lE+08 SN 126 1.2E+06 1.lE+10 FE 59 2.4E+04 7.2E+08 SB 124 5.9E+04 1.4E+09

,CO 58 1.1E+04 5.8E+08 SB 125 1.5E+04 9.lE+08 CO 60 3.2E+04 4.6E+09 TE 127M 3.8E+04 1.0E+09 NI 63 3.4E+05 3.0E+10 TE 129M 3.2E+04 1.3E+09 ZN 65 6.3E+04 1.8E+10 CS 134 7.0E+05 5.6E+10 RB 86 1.9E+05 2.lE+10 CS 136 1.3E+05 5.7E+09 SR 89 4.0E+05 1.lE+10 CS 137 6.1E+05 5.0E+10 SR 90 4.1Et07 1.0E+11 BA 140 5.6E+04 2.oE+08 Y 91 7.0E+04 5.9E+06 CE 141 2.2E+04 3.2E+07 ZR 95 2.2E+04 3.5E+08 CE 144 1.5E+05 1.6E+08 NR 95 1.3E+04 3.8E+08 1 131 1.5E+07 1.0E+12 MO 99 2.6E+02 3.2E+08 1 133 3.6E+06

9. 6E+ 0'l

1 f SR-90 analysis is performed, use P(I) given in 1-131 for unidentified components.

If SR-90 and _-131 analyses are performed, use P(I) given in CS-137 for unidentified components.

If SR-90, I-131, and CS-137 analyses are performed, use P(I) given in ZN-65 for unidentified components.

3

- Fo r t ri t i um, the units of dose parameters are mrem /yr per pCi/m for all pathways, and they must be multiplied by x/Q in Specification 3.II.2.1.B.

2.0 RADIATION MONITORING SETPOINTS Effluent radiation monitor alarm / trip setpoints shall be determined using the calculations presen~;ed in the following sections. The calculations define the relationships between the measured effluent activity, the maximum allowable effluent activity, the effluent flowrate, and the dilution available in the restricted area (as defined for effluent releases in the Technical Specifica-tions) which must be controlled to assure that the instantaneous release rate is not exceeded.

The setpoints shall be determine-for those monitors listed in the appropriate tables of the Technical Specifications.

2.1 LIQUID MONITORS The following equation shall be used to calculate liquid radiation monitor setpoints:

S MPC y

g where:

MPC = the effluent concentration limit implementing 10CFR20 for the site, in pCi/ml.

C = the radioactivity concentration in pCi/ml, in the effluent line prior to dilution and subsequent release, which may be the setpoint and, if so, represents a value which, if exceeded, would result in concentrations exceeding the limits of 10CFR20 in the unrestricted area.

f = the flow measured at the radiation monitor location in gpm.

F = the dilution water flow as measured prior to the release point in gpm.

(Note that if no dilution is provided, C 5 MPC. Also, note that when (F) is large compared to (f), then F + f E F.)

2.2 GAS MONITORS The-following equation shall be used to calculate noble gas radiation monitor setpoints based on Xe-133:

s K.(57Q)Q. < 500 1

1 D.=4.72E+2Cf(SeeSection1.2.1)

I where:

C =

the gross activity in undiluted effluent, in pCi/ml.

f =

the flow from the tank or building and varies for various release sourCOs, in Cfm.

2-1

a

?

i 3

K.

= from Table 1.2-1 for Xe-133, 2.94E-2 meem/yr per pCi/m.

1 (X/Q) the highest calculated _ annual average dispersion parameter for

=

any area at or beyond the unrestricted area boundary for long term releases.

t i

4 4

1 A

4 4

d i

L t

b i

4 f

k l

i i

f i

2-2

.. ~...-

.. ~..

3.0 DOSE CALCULATIONS 3.1 DOSE MODELS FOR MAXIMUM EXPOSED INDIVIDUAL 3.1.1 Liquid Effluents Of the possible exposure pathways in the aquatic environment, only two contribute significantly to the total dose; these pathways are ingestion of potable water and aquatic foods. The dose contributions, from these path-ways, for measured quantities of radioactive materials identified in liquid effluents released to unrestricted areas shall be calculated for the maxi-mum exposed individual in each age group using:

m I [A,g I At C F]

D =

g gg g i

E=1 where:

D = the cumulative dose commitment to the total body or any organ, I,

for an individual of age group, a, from the liquid effluent m

for the total time period I Atg, in mrem.

2=1 at = the length of the Ath time period over which C and F are g

gg g

averaged for all liquid releases, in hours.

Cgg= the average concentration of radionuclide, 'i', in undiluted liquid effluent during time period At from any liquid release, in g

pCi/ml.

F = the near field average dilution factor for C during any liquid g

g effluent release where:

f FE=F+f where:

o = recirculation factor at equilibrium f = liquid radwaste flow, in gpm.

F = dilution flow, in gpm.

A.

= the site related ingestion dose commitment factor for an individual of age group, a, to the total body or any organ,

'I',

for each identi-fled principal gamma and beta emitter, mrem /hr per pCi/ml.

A.t = 1.14E5 (Uaw/D

+U BF )DF t al w

aF i at where:

8 3

1.14E5 = 10 pCi/pci x 10 ml/kg + 8760 hr/yr.

3-1

U,

= Water consumption by age group, f/yr.

infant 330 child 510 teen 510 adult 730 D = Dilution factor from the near field area to the potable water intake.

U,7 = fish consumption by age group, kg/yr.

Infant child 6.9 teen 16 adult 21 BF. = Bioaccumulation factor for radionuclide, 'i', in fish, pCi/kg per pCi/1, from Table 3.1-1.

DF.* = Dose conversion factor for radionuclide, 'i', by age group in pre-selected organ, I, in mrem /pCi, from Tables 3.1-2, 3.1-3, 3.1-4, and 3.1-5, respectively.

3.1.2 Gaseous Effluents The dose contributions from measured quantities of radioactive materials identified in gaseous effluent released to unrestricted areas shall be cal-culated for the maximum exposed individual using the following equations:

3.1.2.1 Noble Gases For gamma radiation:

^

~

D = 3.17 E-8 I M. [(X7Q) Q l Y

1 i

i=1 For beta radiation:

~

p = 3.17 E-8 I Ng [(X/Q) Q l D

i i=1 where:

3.17 x 10 8 = The inverse of the number of seconds in a year.

M.

= The air dose factor due to gamma emissions for each identified noble 3

gas radionuclide, in mrad /yr per pCi/m from Table 1.2-1.

N.

= The air dose factor due to beta emissions for each identified noble 3

gas radionuclide, in mead /yr per pCi/m from Table 1.2-1.

(X/Q) = The highest calculated annual average relative concentration for any area at or beyond the unrestricted area boundary.

~

Q *.

= The release of noble gas radionuclides, 'i', in gaseous effluents, in pCi.

3-2

3.1.2.2 Radioiodines, Particulates, and Others These calculations apply to all radiciodines, radioactive materials in partic-ulate form acd radionuclides other than noble gases with half-lives greater than 8 days:

s D = 3.17 E-8 I Rg [WQ ]

g i

where:

3.17 x 10 8 = The inverse of the number of seconds in a year.

s Q = The release of radioiodines, radioactive materials in particulate form g

and radionuclides other than noble gases in gaseous effluents, 'i',

in pCi. Releases shall be cumulative over the calendar quarter or year as appropriate.

W = The annual average dispersion or deposition parameter for estimating the dose to an individual at the controlling location.

3 W = (X/Q) for the inhalation pathway, in sec/m.

W = (D/Q) for the food and ground plane pathways, in meters 2, 2

R. = The dose factor for each identified radionuclide, 'i', in m (mrem /yr) per 3

pCi/sec or arem/yr per pCi/m.

R.=Rh[X/Q]+Rh[D/Q]+Rh[D/Q,X/Q]+R9[D/Q,X/y]+RY[D/Q,X/Ql 1

1 1

1 where:

InhalationPathwayFactor,Rf[X/Q]

1 Rf [X/Q] = K'(BR), (DFA ), (mrem /yr per pCi/m )

3 g

where:

6 K'

= a constant of unit conversion, 10 pCi/pCi.

3 (BR), = the breathing rate of the receptor of age group (a), in m /yr.

The breathing rates (BR) for the various age groups are tabulated below, as given in Regulatory Guide 1.109.

Age Group (a)

Breathing Rate (m3/yr)

Infant 1400 Child 3700 Teen 8000 Adult 8000 3-3

1 (DFA.)* = the maximum organ inhalation dose factor the receptor of age group (a) for the ith radionuclide, in mrem /pci. The total body is con-sidered as an organ in the selection of (DFA ),.

See Tables 3.1-6, g

3.1-7, 3.1-8, and 3.1-9.

Inhalation dose factors (DFA )

for the various age groups are given in g

i Tables 3.1-6, 3.1-7, 3.1-8, and 3.1-9 (taken from Regulatory Guide 1.109 (Rev.1)).

Ground Plane Pathway Factor, R [D/Q]

t 2

R [D/Q) = K'K"(SF)DFG [(1-e i )/A ] (m mrem /yr per pCi/sec) 1 g

where:

K'

= a constant of unit conversion, 108 pCi/pci.

K"

= a constant of unit conversion, 8760 hr/ year.

A

= the decay constant for the ith radionuclide, sec 1, 8

t

= the exposure time, 4.73 x 10 sec (15 years).

DFG = the ground plane dose conversion factor for the ith radionuclide (mrem /hr g

2 per pCi/m ),

SF

= the shielding factor (dimensionless), 0.7 (Regulatory Guide 1.109 (Rev. 1)).

Ground plane dose conversion factors, DFG, are found in Table 3.1-10.

Grass-Cow-Hilk Pathway Factor, R [D/Q]

( * + (1-f f )e ^i h

~

Q (U )

-A.t ff Ps i f Rf[D/Q)=K'E

,"{

F,(r)(DFL ),

F e

g 1

w p

s 2

(m mrem /yr per pCi/sec) where:

8 K'

= a constant of unit conversion, 10 pCi/pCi.

Q

= the cow's consumption rate, in kg/ day (wet weight), 50 (Regulatory F

Guide 1.109 (Rev. 1)).

U

= the receptor's milk consumption rate for age (a), in liters /yr.

ap (liters /yr) - Infant U

330

- Child 330

- Teen 400

- Adult 310 (Regulatory Guide 1.109 (Rev. 1))

3-4

.~.

Y

= the agricultural productivity by unit area of pasture feed grass, P

in kg/m2, o,7, Y

= the agricultural productivity by unit area of stored feed, in s

2 kg/m, 2.0.

F,

= the stable element transfer coefficients, in days / liter, Table 3.1-11.

r

= fraction of deposited activity retained on cow's feed grass, r = 1 l

for radiciodine and r = 0.2 for particulates (Regulatory Guide 1.109).

l (DFL.)* = the maximum organ ingestion dose factor for the ith radionuclide for the receptor in age group

'a', in mrem /pCi. See Tables 3.1-2, j

3.1-3, 3.1-4, and 3.1-5.

~1 A

= the decay constant for the ith radionuclide, in sec g

I A

= the decay constant for removal of activity on leaf and plant surfaces i

by weathering, 5.73 x 10 sec (corresponding to a 14 day half-life).

~7

~1 l

=thetransgorttimefrompasturetocow, to milk, to receptor, in sec, t g 1.73 x 10 (2 days).

t

= the transport time from pasture, to harvest, to cow, to milk, to re-h 8

ceptor, in sec, 7.78 x 10 (90 days).

f

= fraction of the year that the cow is on pasture (dimensionless), 1.0.

i p

f

= fraction of the cow feed that is pasture grass while the cow is on s

pasture (dimensionless), 1.0.

E

= an adjustment fraction which accounts for the fraction of radionu-clides in elemental form which contribute dose for this pathway, E = 0.5 for radiciodine, E = 1.0 for all others.

The concentratiou of tritium in milk is based n the airborne concent' ration C

rather than the deposition. Therefore, the R is based on [X/Q]:

g 3

R [X/Q] = K'K'"F,Q U,p(DFL ), {0.75(0.5/H)] (mrem /yr per pCi/m )

F g

where:

K'"

= a constant of unit conversion, 103 gm/kg.

3 H

= absolute humidity of the atmosphere, 8 gm/m, (Regulatory Guide 1.109) 4 0.75 = the fraction of total feed that is water.

0.5

= the ratio of the specific activity of the feed grass water to the atmos-pheric water.

3-5 i

F Grass-Cow-Meat Pathway F.sctor, R [D/Q)

The integrated concentration in meat follows in a similar manner to the develop-ment for the milk pathway, therefore:

Q (Uap) ff (1-f f )e' i'h

-A t p

ps if R [D/Q] = K, F (r)(DFL ),

(s e

i, g

g w

p s

2 (m. mrem /yr per pCi/sec) where:

F

= the stable element transfer coefficients, in days /kg, Table 3.1-11.

g U

= the receptor's meat consumption rate for age (a), in kg/yr.

ap(kg/yr) - Infant U

0

- Child 41

- Teen 65

- Adult 110 Taken from Regulatory Guide 1.109 (Rev. 1).

t

= the transport time from pasture to receptor, in sec.

g t

= the transport time from crop field to receptor, in sec.

h The concentration of tritium in meat is based on its airborne concentration g

rather than the deposition. Therefore, the R is based on [X/Q):

g 3

R [X/Q] = K'K'"F Q U,p(DFL ), [0.75(0.5/H)] (mrem /yr per pCi/m )

fF g

where all terms are defined above.

V Vegetation Pathway Factor, R [D/Q]

g The integrated concentration in vegetation consumed by man follows the expres-sion developed in the derivation of the milk factor. Man is considered to consume two types of vegetation (fresh and stored) that differs only in the time period between harvest and consumption, therefore:

RY[D/Q]=K'

(#

t Y (A + A )

(DFL.)a Ufe

+Ufe i

aL ag y g a

(m2. mrem /yr per pCi/sec) where:

6 K 's = a constant of unit conversion, 10 pCi/pci.

L U = the consumption rate of fresh leafy vegetation by the receptor in age group (a), in kg/yr.

3-6

L U = (kg/nr) - Infant 0

- Child 26

- Teen 42

- Adult 64 3

U = the consumption rate of stored vegetation by the receptor in age group (a), in kg/yr.

U = (kg/yr) - Infant 0

- Child 520

- Teen 630

- Adult 520 f = the fraction of the annual intake of fresh leafy vegetation grown locally.

g f = the fraction of the annual intake of stored vegetation grown locally.

8 t = the average time between harvest of leafy vegetation and its consumption, 4

in seconds, 8.6 x 10 (1 day).

h = the average time between harvest of stored vegetation and its consumption, t

8 in seconds, 5.18 x 10 (60 days).

2 Y = the vegetation area density, 2.0 kg/m,

y and all other factor", are previously defined.

Theconcentrationoftritiuminvegetationisbasegontheairborneconcentra-tion rather than the deposition. Therefore, the R. is based on [X/Ql:

1 3

3 R [X/Q] = K'K'"

ft+Uf (DFL ),

[0.75(0.5/H)] (mrem /yr per pCi/m ).

g All terms defined previously.

3.1.3 Direct Radiation Direct radiation is that radiation from confined sources and does not include any external component from radioactive effluents. The point kernel method has been used to calculate offsite dose rates from radioactive materials stored in the refueling water storage tanks and reactor makeup water storage tanks.

Dose calculations using this method performed for Duke Nuclear Stations indicate direct radiation doses are much less than 1 mcem/yr. and, therefore, negligible contributions to either individual or population doses. Direct radiation doses will not be calculated routinely.

3.2 SIMPLIFIED DOSE ESTIMATES To estimate the cumulative dose contributions to the maximum exposed individ-ual for 31 day dose calculations, the calculations presented in Section 3.1 i

can be simplified. The simplified calculations would be for an individual in the critical population using only data for the critical pathway and, critical radionuclide(s). Critical populations, critical pathways, and criti-cal radionuclides have been determined for each Duke Nuclear Station from the dose calculations performed to evaluate compliance with Appendix I to 10CFR50.

3-7

Simplified 31-day dose calculations are presented in the section on site specific information.

3.3 FUEL CYCLE CALCULATIONS In accordance with the requirements of 40CFR190, the annual dose commitment to any member of the general public shall be calculated to assure that doses are limited to 25 millirems to the total body or any organ with the exception of the thyroid which is limited to 75 millirems.

In accordance with the requirements of the Technical Specifications, the annual dose commitment shall also be calculated any time that one of the quarterly dose limits of the Technical Specifications is exceeded; these annual dose commitments may not just be calculated for the calendar year.

The " Uranium fuel cycle" is definad in 40CFR Part 190.02(b) as:

" Uranium fuel cycle means the operations of milling or uranium ore, chemical conversion of uranium, isotopic enrichment of uranium, fab-rication of uraniua fuel, generation of electricity by a light-water-cooled nuclear power plant using uranium fuel, and reprocessing of spent uranium fuel, to the extent that these directly support the pro-duction of electrical power for public use utilizing nuclear energy, but excludes mining operations, operations at waste disposal sites, transportation of any radioactive material in support of these opera-tions, and the reuse of recovered non-uranium special nuclear and by product materials from the cycle."

Based on this definition of the fuel cycle and the information in 10CFR51 Table S-3 and WASH-1248, the radiological impact of the following operations has been assessed for Duke Nuclear Stations:

3.3.1 Milling No milling operations occur within fifty miles of any Duke Nuclear Station.

The increment of dose from milling operations to any individual within fifty miles of any Duke Nuclear Station is negligible.

3.3.2 Conversion No uranium hexafluoride production occurs within fif ty miles of any Duke Nuclear Station. The increment of dose from UFs production to any individual within fifty miles of any Duke Nuclear Station is negligible.

3.3.3 Enrichment No uranium enrichment operations occur within fifty miles of any Duke Nuclear Station. The increment of dose from enrichment operations to any individual within fifty miles of any Duke Nuclear Station is negligible.

l I

l 3.3.4 Fuel Fabrication 1

No fuel fabrication operations occur within fif ty miles of any Duke Nuclear l

Station. The increment of dose from fabrication operations to any individual within fif ty miles of any Duke Nuclear Station is negligible.

3-8

i 3.3.5 Nuclear Power Production The production of electricity for public use using light-water-cooled nuclear power stations results in increments of dose to individuals within fif ty miles of any station due to liquid and gaseous effluent releases and direct radiation or skyshine. The increments of dose resulting from liquid and gaseous effluent releases will be calculated using the methodology present ed in Sections 3.1.1 and 3.1.2.

The dose from direct radiation, skyshine, and :4diation from the station storage facilities has been estimated using conservative assumptions (see Section 3.1.3), the estimates of this dose will be presented in the section on site specific information.

In certain situations more than one nuclear power station site may contri-bute to the doses to be considered in making fuel cycle dose assessments in accordance with 40CFR190. Situations involving more than one station will be presented in the section on site specific information.

3.3.6 Fuel Reprocessing No fuel reprocessing operations occur within fifty miles of any Duke Nuclear Station. The increment of dose from reprocessing operations to any individual within fifty miles of any Duke Nuclear Station is negligible.

To summarize, only dose increments from nuclear power production operations (Section 3.3.5) need be considered in calculations to demonstrate compliance with the requirements of 40CFR190.

3.4 POPULATION DOSES To comply with the reporting requirements of the semiannual effluent summary, significant population dose contributions from all receiving-water-related pathways, from gaseous effluents to a distance of 50 miles from the site, and from direct radiation from the station should be calculated. A significant dose contribution is defined as 10 percent or more of total dose.

3.4.1 Liquid Effluents As stated in Section 3.1.1 of the possible exposure pathways in the aquatic environment, only two contribute significantly to the total dose; these pathways are ingestion of potable water and aquatic foods. The dose contri-butions from these pathways, for measured quantities of radioactive materials identified in liquid effluents released to unrestricted areas, shall'be calculated for the exposed population using:

DP = 0.001I P I I [A I at C.2 E]

F I

d it =1 2 1 f

d ai where:

P D = the population dose commitment to the total body or any organ, I, from m

the liquid effluent for the total time period I at2' I" "'"~#***

t=1 3-9

t 4++/

%'+4

%8 k &>

N

_ EEm e 1,em TEST TARGET (MT-3) 1.0

!e E2 Daa ii!?

{U l lie M

I.l

\\

=

[ I.8 l.25 1.4 1.6 c

6" MICROCOPY RESOLUTION TEST CHART 4Wl %/////

l%s

?

f/ 3*/

Op////

i 3

)

1 i

i I

l L.

.._.___s-

^

- - - ~

}

0.001 = conversion from millires to rem.

exposed population in region d.

P :

d and F are averaged

'Atg = the length of the 2th time period over which Cgg g

for all liquid releases, in hours.

C

= the average concentration of radionuclide, 'i', in undiluted liquid g

effluent during time period At from any liquid release, in pCi/ml.

g F = the near field average dilution factor for C during any liquid g

gg effluent release where:

F fo g=F+f where:

c = recirculation factor at equilibrium f = liquid radwaste flow, in gpm F = dilution flow, in gpm.

A.

= the site related ingestion dose commitment factor for an individual of age group, a, to the total body or any organ, I,

for each identified principal gamma and beta emitter, mrem /hr per pCi/ml.

1.14E5 (Uaw/D + U JF. )DF. t A

.t

=

at w

ar 1

al where:

8 3

1.14E5 = 10 pCi/pCi x 10 ml/kg + 8760 br/yr.

U,

= water consumption by age group, x/yr.

infant 0

child 260 teen 260 adult 370 D = dilution factor from the near field area to the potable water intake.

U

= fish consumption by age group, kg/yr.

af infant 0

child 2.2 teen 5.2 adult 6.9 BF. = bioaccumulation factor for radionuclide, i, in fish, pCi/kg per pCi/2, I

from Table 3.1-1.

l DF.I = dose conversion factor for radionuclide, i, by age group in pre-selected organ, I, in mrem /pC1, from Tables 3.1-2, 3.1-3, 3.1-4, and 3.1-5, respectively.

3-10

~~

[

i

)

I 3.4.2 Gaseous Effluents The dose contributions to the exposed population from measured quantities of radio-active materials identified in gaseous effluents released to unrestricted areas shall be calculated by sectors using the methodology in the following sections.

The 50-mile region should be divided 160 subregions formed by sectors centered on the 16 compass points and annuli at distances 1, 2, 3, 4, 5, 10, 20, 30, 40, and 50 miles from the center of the facility.

3.4.2.1 Noble Gases t

t For gamma radiation:

EMi[X74Di]

D =3.17E-11f.Pd For beta radiation:

DP = 3.17E-11 T P I N.[X/Q Qi]

s 3 dt t where:

3.17E-11 = The inverse of the number of seconds in a year times the conversion of millirems to rems.

P

= Population in subregion d d

1 M.

= The air dose factor due to gamma emissions for each identified noble 3

gas radionuclide, in mrad /yr per pCi/m from Table 1.2.1.

N.

= The air dose factor due to beta emissions for each identified noble 1

3 gas radionuclide, in mrad /yr per pCi/m from Table 1.2-1.

(X/Q)

= The highest calculated annual average dispersion parameter for any area at or beyond the unrestricted area boundary.

s Q

= The release of noble gas radionuclides, 'i', in gaseous effluents, in pCi.

g 3.4.2.2 Radioiodines, Particulates, and Others These calculations apply to all radioiodines, radioactive materials in particulate form and radionuclides other than noble gases with half-lives greater than 8 days:

g[WD]

D =3.17E-11gPdkId R g

where:

3.17E-11 = The inverse of the number of seconds in a year times the conversion from millirems to rens.

P

= The population in subregion d d-3-11 m..

i f

= The fraction of the population in subregion d that is in age group a.

d s

Q

= The release of radioiodines, radioactive materials in particulate 1

form and radionuclides other than noble gsses in gaseous effluents,

'i', in pCi. Releases shall be cumulative over the calendar quarter or year as appropriate.

W

= The annual average dispersion or deposition parameter for estimating the dose to an individual at the controlling location 3

W=

(X/Q) for the inhalation pathway, in sec/m

~2 W=

(D/Q) for the food and ground plane pathways, in meters, 2

R.

= The dose factor for each identified radionuclide, 'i', in m (mrem /yr) 3 per pCi/sec or arem/yr per pCi/m.

R.=Rf[X/Q]+Rh[D/Q]+Ri[D/Q,X/Q)+[D/Q,X/Q]+RY[D/Q,X/Q) 1 i

t where:

Inhalation Pathway Factor, Rf [X/Q}

3 Rg [X/Q) = K' (BR)a (mrem /yr per pCi/m )

where:

6 K'

= a constant of unit conversion, 10 pCi/pci.

(BR)a = the breathing rate of the receptor of age group (a), in m /yr.

3 The breathing rates (BR) for the various age groups are tabulated below, as given in Regulatory Guide 1.109.

3 Age Group (a)

Breathing Rate (m /vr)

Infant 1400 Child 3700 Teen 8000 Adult 8000 (DFA.)* : the maximum organ inhalation dose factor the receptor of age group (a) for the ith radionuclide, in mrem /pCi. The total body is con-sidered as an organ in the selection of (DF.)*.

See Tables 3.1-6, 3.1-7, 3.1-8, and 3.1-9.

Inhalation dose factors (DFA.)

for the various age groups are given in Tables 3.1-6, 3.1-7, 3.1-8, and 3.1*9"(taken f rom Regulatory Guide 1.109 (Rev. 1)).

3-12 l

l

GroundPlanePathwayFactor,R((D/Q]

R G [D/Q) = K'K"(SF)DFG [1-e i E ] (m2. mrem /yr per pCi/sec) g g

g where:

8 K'

= a constant of unit conversion, 10 pCi/pCi.

1 K"

= a constant of unit conversion, 8760 hr/ year.

~1 A

= the decay constant for the ith radionuclide, sec f

8 t

= the exposure time, 4.73 x 10 sec (15 years).

DFG.= the ground plane dose conversion factor for the ith radionuclide (mrem /hr 2

per pCi/m ),

SF = the shielding factor (dimensionless), 0.7 (Regulatory Guide 1.109 (Rev. 1)).

Ground place dose conversion factors, DFG, are found in Table 3.1-10.

Grass-Cow-MilkPathwayFactor,Rh[D/Q]

Q (Uap) ff (1-f f )e' i'h

-A.t Ps ps if p

Rh[D/Q]=K'E F (r)(DFL.)a Y

Y e

1 Ag+A a

1 s

2 (m. mrem /yr per pCi/sec) where:

K'

= a constant of unit conversion, 10s pCi/pci.

Q

= the cow's consumption rate, in kg/ day (wet weight). 50 Regulatory F

Guide 1.109 (Rev. 1)).

U

= the receptor's milk consumption rate for age (a), in liters /yr.

Uap = (liters /yr) - Infant 330

- Child 170

- Teen 200

- Adult 110 (Regulatory Guide 1.109 (Rev. 1))

l l

Y

= the agricultural productivity by unit area of pasture feed grass, P

2 in kg/m, 0.7.

l Y

= the agricultural productivity by unit area of stored feed, in 2

i kg/m, 2.0.

F,

= the stable eleraent transfer coefficients, in days / liter, Table 3.1-11.

r

= fraction of deposited activity retained on cow's feed grass, r=1 for radioiodine and r = 0.2 for particulates (Regulatory Guide 1.109).

3-13

~

(Di g),

= the maximum organ ingestion dose factor for the ith radionuclide for the receptor in age group

'a', in mrem /pCi. See Tables 3.1-2, 3.1-3, 3.1-4, and 3.1-5.

~1 A

= the decay constant for the ith radionuclide, in sec f

A

= the decay constant for removal of_ activity on leaf and plant y

7 1

surfaces by weathering, 5.73 x 10 see (corresponding to a 14 day half-life).

=thetransgorttimefrompasturetocow, to milk, to receptor, in sec, t g 1.73 x 10 (2 days).

f

= the transport time f ar pasture, to harvest, to cow, to milk, to re-8 8

ceptor, in sec, 7.7f, x 10 (90 days).

f

= fraction of the yerr that the cow is on pasture (dimensionless), 1.0.

p f,

= fraction of the cow feed that is pasture grass while the cow is on pasture (dimensionless), 1.0.

E

= an adjustment fraction which accounts for the fraction of radionu-clides in elemental form which contribute dose for this pathway.

E = 0.5 for radioiodine, E = 1.0 for all others.

The concentration of tritium in milk is based a the airborne concentration C

rather than the deposition. Therefore, the R is based on [X/Q]:

g Rf[X/Q]=K'K'"F,QU (DFL ), [0.75(0.5/H)] (mrem /yr per pCi/m )

3 p

g where:

3 K'

= a constant of unit conversion, 10 gm/kg.

3 H

= absolute humidity of the atmosphere, 8 gm/m, (Regulatory Guide 1.109) 0.75 = the fraction of total feed that is water.

0.5 = the ratio of the specific activity of the feed grass water to the atmospheric water.

Grass-Cow-Meat Pathway Factor, R9[D/Q]

1 The integrated concentration in meat follows in a similar manner to the develop-ment for the milk pathway, therefore:

Q (Uap) ff (1-f f )e ih

-A.t F

P*

9*

R [D/Q] = K, F (r)(DFL ),

y

+

e f

f 1

w p

s 2

(m mrem /yr per pCi/sec) 3-14

where:

F

= the stable element transfer coefficients, in days /kg, Table 3.1-11.

f U,p = the receptor's meat canemption rate for age (a), in kg/yr.

"E(kg/yr) - Infant U

J

- Child 37

- Teen 59

- Adult 95 Taken from Regulatory Guide 1.109 (Rev. 1).

t

= the transport time from pasture to receptor, in sec.

g t

= the transport time from crop field to receptor, in sec.

h The concentration of tritium in meat is based on its airborne concentration g

rather than the deposition. Therefore, the R is based on [X/Q]:

g 3

R [X/Q] = K'K'"F Q U (DFL ), [0.75(0.5/H)] (mrem /yr per pCi/m )

gp g

where all terms are defined above.

V Vegetation Pathway Factor, R [D/Q]

g The integrated concentration in vegetation consumed by man follows the expres-sion developed in the derivation of the milk factor. Man is considered to consume two types of vegetation (fresh and stored) that differs only in the time period between harvest and consumption, therefore:

b f"

R [D/Q] = K' y (g,A)

(DFL ),

t g

e 1

(m2. mrem /yr per pCi/sec) where:

K'

= a constant of unit conversion, 108 pCi/pCi.

L U

= the consumption rate of fresh leafy vegetation by the receptor in age group (a), in kg/yr.

L (kg/hr) - Infant 0

U =

- Child 26

- Teen 42

- Adult 64 i

S U = the consumption rate of stored vegetation by the receptor in age group (a), in kg/yr.

[ = (kg/yr) - Infant 0

- Child 200 l

- Teen 240 l

- Adult 190 3-15 l

l

f = the fraction of the annual intake of fresh leafy vegetation grown locally.

g f = the fraction of the annual intake of stored vegetation grown locally.

g g = the average time between harvest of leafy vegetation and its consumption, t

4 in seconds, 8.6 x 10 (1 day).

h = the average time between harvest of stored vegetation and its consumption, t

in seconds, 5.18 x los (60 days).

2 Y = the vegetation area density, 2.0 ks/m,

y and all other factors are previously defined.

The concentration of tritium in vegetation is based o9 the airborne concen-tration rather than the deposition. Therr fore, the R is based on [X/Q]:

g R [X/Q) = K'K'" Uffg+Uf 6

3 (DFL ), [0.75 (0.5/H)] (mrem /yr per pCi/m ).

g g

All terms defined previously.

5.4.3 Direct Radiation Direct radiation exposure contributions to the dose of either the maximum exposed individual or to the population within 50 miles of any Duke Nuclear Station are negligible using the point kernel method of evaluating offsite dose rates from radioactive material stored outside buildings in the refueling water storage tanks and reactor makeup water storage tanks. Direct radiaiton doses will not be routinely evaluated.

i

.i 3-16

TABLE 3.1-1*

(1 of 1)

BI0 ACCUMULATION FACTORS TO BE USED IN THE ABSENCE OF SITE-SPECIFIC DATA (pCi/kg per pCi/ liter) i FRESHWATER ELEMENT FISH INVERTEBRATE H

9.0E-01 9.0E-01 C

4.6E-03 9.1E-03 Na 1.0E-02 2.0E 02 P

1.0E 05 2.0E 04

~

Cr 2.0E 02 2.0E 03 Mn 4.0E 02 9.0E 04 Fe 1.0E 02 3.2E 03 Co 5.0E 01 2.0E 02 Ni 1.0E 02 1.0E 02 Cu 5.0E 01 4.0E 02 Zn 2.0E 03 1.0E 04 Br 4.2E 02 3.3E 02 Rb 2.0E 03 1.0E 03 Sr 3.0E 01 1.0E 02 Y

2.5E 01 1.0E 03 Zr 3.3E 00 6.7E 00 4

Nb 3.0E 04 1.0E 02 Mo 1.0E 01 1.0E 01 i

Tc 1.5E 01 5.0E 00 Ru 1.0E 01 3.0E 02

=

Rh 1.0E 01 3.0E 02 Te 4.0E 02 6.1E 03 I

1.5E 01 5.0E 00 Cs 2.0E 03 1.0E 03 Ba 4.0E 00 2.0E 02 La 2.5E 01 1.0E 03 Ce 1.0E 00 1.0E 03 Pr 2.5E 01 1.0E 03 Nd 2.5E 01 1.0E 03 W

1.2E 03 1.0E 01 Np 1.0E 01 4.0E 02

Table taken from Regulatory Guide 1.109 (Rev.1)

TABLE 3.3-1 (1 of 1)

TABLE 3.1-2 (1 of 3)

INGESTION DOSE FACTORS FOR ADULTS (MREM PER PCI INGESTED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI i

H 3

NO DATA 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 1.05E-07 C 14 2.84E-06 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 5.68E-07 NA 24 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 1.70E-06 P 32 1.93E-04 1.20E-05 7.46E-06 NO DATA NO DATA NO DATA 2.17E-05 CR 51 NO DATA NO DATA 2.66E-09 1.59E-09 5.86E-10 3.53E-09 6.69E-07 MN 54 NO DATA 4.57E-06 8.72E-07 NO DATA 1.36E-06 NO DATA 1.40E-05 MN 56 NO DATA 1.15E-07 2.04E-08 NO DATA 1.46E-07 NO DATA 3.67E-06 FE 55 2.75E-06 1.90E-06 4.43E-07 NO DATA NO DATA 1.06E-06 1.09E-06 FE 59 4.34E-06 1.02E-05 3.91E-06 NO DATA NO DATA 2.85E-06 3.40E-05 CO 58 NO DATA 7.45E-07 1.67E-06 NO DATA NO DATA NO DATA 1.51E-05 CO 60 NO DATA 2.14E-06 4.72E-06 NO DATA NO DATA NO DATA 4.02E-05 NI 63 1.30E-04 9.01E-06 4.36E-06 NO DATA NO DATA NO DATA 1.88E-06 NI 65 5.28E-07 6.86E-08 3.13E-08 NO DATA NO DATA NO DATA 1.74E-06 CU 64 NO DATA 8.33E-08 3.91E-08 NO DATA 2.10E-07 NO DATA 7.10E-06 ZN 65 4.84E-06 1.54E-05 o.96E-06 NO DATA 1.03E-05 NO DATA 9.70E-06 ZN 69 1.03E-08 1.97E-08 1.37E-09 NO DATA 1.28E-08 NO DATA 2.96E-09 BR 83 NO DATA NO DATA 4.02E-08 NO DATA NO DATA NO DATA 5.79F-08 BR 84 NO DATA NO DATA 5.21E-08 NO DATA NO DATA NO DATA 4.09E-13 BR 85 NO DATA NO DATA 2.14E-09 NO DATA NO DATA NO DATA LT E-24 RB 86 NO DATA 2.11E-05 9.83E-06 NO DATA NO DATA NO DATA 4.16E-06 RB 88 NO DATA 6.05E-08 3.21E-08 NO DATA NO DATA NO DATA 8.36E-19 RB 89 NO DATA 4.01E-08 2.82E-08 NO DATA NO DATA NO DATA 2.33E-21 SR 89 3.08E-04 NO DATA 8.84E-06 NO DATA NO DATA NO DATA 4.94E-05 SR 90 7.58E-03 NO DATA 1.86E-03 NO DATA NO DATA NO DATA 2.19E-04 SR 91 5.67E-06 NO DATA 2.29E-07 NO DATA NO DATA NO DATA 2.70E-05 SR 92 2.15E-06 NO DATA 9.30E-08 NO DATA NO DATA NO DATA 4.26E-05 Y 90 9.62E-09 NO DATA 2.58E-10 NO DATA NO DATA NO DATA 1.02E-04 Y 91M 9.09E-11 NO DATA 3.52E-12 NO DATA NO DATA NO DATA 2.67E-10 Y 91 1.41E-07 NO DATA 3.77E-09 NO DATA NO DATA NO DATA 7.76E-05 Y 92 8.45E-10 NO DATA 2.47E-11 NO DATA NO DATA NO DATA 1.48E-05 Y 93 2.68E-09 NO DATA 7.40E-11 NO DATA NO DATA NO DATA 8.50E-05 ZR 95 3.04E-08 9.75E-09 6.60E-09 NO DATA 1.53E-08 NO DATA 3.09E-05 ZR 97 1.68E-09 3.39E-10 1.35E-10 NO DATA 5.12E-10 NO DATA 1.05E-04 l

TABLE 3.1-2 l

(1 of 3)

TABLE 3.1-2 (2 of 3)

INGESTION DOSE FACTORS FOR ADULTS (MREM PER PCI INGESTED)

NUCLIDE BONE LIVER T.B0DY THYROID KIDNEY LUNG GI-LLI TE 129 3.14E-08 1.18E-08 7.65E-09 2.41E-08 1.32E-07 NO DATA 2.37E-08 TE 131M

_1.73E-06 8.46E-07 7.05E-07 1.34E-06 8.57E-06 NO DATA 8.40E-05 TE 131 1.97E-08 8.23E-09 6.22E-09 1.62E-08 8.63E-08 NO DATA 2.79E-09 TE 132 2.52E-06 1.63E-06 1.53E-06 1.80E-06 1.57E-05 NO DATA 7.71E-05 I 130 7.56E-07 2.23E-06 8.80E-07 1.89E-04 3.48E-06 NO DATA 1.92E-06 I 131 4.16E-06 5.95E-06 3.41E-06 1.95E-03 1.02E-04 NO DATA 1.57E-06 I 132 2.03E-07 5.43E-07 1.90E-07 1.90E-05 8.65E-07 NO DATA 1.02E-07 I 133 1.42E-06 2.47E-06 7.53E-07 3.63E-04 4.31E-06 NO DATA 2.22E-06 I 134 1.06E-07 2.88E-07 1.03E-07 4.99E-06 4.58E-07 NO DATA 2.51E-10 1 135 4.43E-07 1.16E-06 4.28E-07 7.65E-05 1.86E-06 NO DATA 1.31E-06 CS 134 6.22E-05 1.48E-04 1.21E-04 NO DATA 4.79E-05 1.59E-05 2.59E-06 CS 136 6.51E-06 2.57E-05 1.85E-05 NO DATA 1.43E-05 1.96E-06 2.92E-06 CS 137 7.97E-05 1.09E-04 7.14E-05 NO DATA 3.70E-05 1.23E-05 2.11E-06 CS 138 5.52E-08 1.09E-07 5.40E-08 NO DATA 8.01E-08 7.91E-09 4.65E-13 BA 139 9.70E-08 6.91E-11 2.84E-09 NO DATA 6.46E-11 3.92E-11 1.72E-07 BA 140 2.03E-05 2.55E-08 1.33E-06 NO DATA 8.67E-09 1.46E-08 4.18E-05 BA 141 4.71E-08 3.56E-11 1.59E-09 NO DATA 3.31E-11 2.02E-11 2.22E-17 BA 142 2.13E-08 2.19E-11 1.34E-09 NO DATA 1.85E-11 1.24E-11 3.00E-26 LA 140 2.50E-09 1.26E-09 3.33E-10 NO DATA NO DATA NO DATA 9.25E-05 LA 142 1.28E-10 5.82E-11 1.45E-11 NO DATA NO DATA NO DATA 4.25E-07 CE 141 9.36E-09 6.33E-09 7.18E-10 NO DATA 2.94E-09 NO DATA 2.42E-05 CE 143 1.65E-09 1.22E-06 1.35E-10 NO DATA 5.37E-10 NO DATA 4.56E-05 CE 144 4.88E-07 2.04E-07 2.62E-08 NO DATA 1.21E-07 NO DATA 1.65E-04 PR 143 9.20E-09 3.69E-09

.56E-10 NO DATA 2.13E-09 NO DATA 4.03E-05 PR 144 3.01E-11 1.25E-11 1.53E-12 NO DATA 7.05E-12 NO DATA 4.33E-18 ND 147 6.29E-09 7.27E-09 4.35E-10 NO DATA 4.25E-09 NO DATA 3.49E-05 W 187 1.03E-07 8.61E-08 3.01E-08 NO DATA NO DATA NO DATA 2.82E-05 NP 239 1.19E-09 1.17E-10 6.45E-11 NO DATA 3.65E-10 NO DATA 2.40E-05 I

i TABLE 3.1-2 (2 of 3)

TABLE 3.1-2 (3 of 3)

INGESTION DOSE FACTORS FOR ADULTS (MREM PER PCI INGESTED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI NB 95 6.22E-09 3.46E-09 1.86E-09 NO DATA 3.42E-09 NO DATA 2.10E-05 MO 99 NO DATA 4.31E-06 8.20E-07 NO DATA 9.76E-06 NO DATA 9.99E-06 TC 99M 2.47E-10 6.98E-10 8.89E-09 NO DATA 1.06E-08 3.42E-10 4.13E-07 TC 101 2.54E-10 3.66E-10 3.59E-09 NO DATA 6.59E-09 1.87E-10 1.10E-21 RU 103 1.85E-07 NO DATA 7.97E-08 NO DATA 7.06E-07 NO DATA 2.16E-05 RU 105 1.54E-08 NO DATA 6.08E-09 NO DATA 1.99E-07 NO DATA 9.42E-06 RU 106 2.75E-06 NO DATA 3.48E-07 NO DATA 5.31E-06 NO DATA 1.78E-04 AG 110M 1.60E-07 1.48E-07 8.79E-08 NO DATA 2.91E-07 NO DATA 6.04E-05 TE 125M 2.68E-06 9.71E-07 3.59E-07 8.06E-07 1.09E-05 NO DATA 1.07E-05 TE 127M 6.77E-06 2.42E-06 8.25E-07 1.73E-06 2.75E-06 NO DATA 2.27E-05 TE 127 1.10E-07 3.95E-08 2.38E-08 8.15E-08 4.48E-07 NO DATA 8.68E-06 TE 129M 1.15E-05 4.29E-06 1.82E-06 3.95E-06 4.80E-05 NO DAT.%

5.79E-05 TABLE 3.1-2 (3 of 3)

TABLE 3.1-3*

(1 of 3)

INGESTION DOSE FACTORS FOR TEENAGER (MREM PER PCI INGESTED)

NUCLIDE JONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H

3 NO DATA 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 1.06E-07 C 14 4.06E-06 S.12E-07 8.12E-07 8.12E-07 8.12E-07.8.12E-07 8.12E-07 NA 24 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 2.30E-06 P 32 2.76E-04 1.71E-05 1.07E-05 NO DATA NO DATA NO DATA 2.32E-05 CR 51 NO DATA NO DATA 3.60E-09 2.00E-09 7.a9E-10 5.14E-09 6.05E-07 MN 54 NO DATA 5.90E-06 1.17E-06 NO DATA 1.76E-06 NO DATA 1.21E-05 MN 56 NO -

1.58E-07 2.81E-08 NO DATA 2.00E-07 NO DATA 1.04E-05 FE 55 3.78E-06 2.68E-06 6.25E-07 NO DATA NO DATA 1.70E-06 1.16E-06 FE 59 5.87E-06 1.37E-05 5.29E-06 NO DATA NO DATA 4.32E-06 3.24E-05 CO 58 NO DATA 9.72E-07 2.24E-06 NO DATA NO DATA NO DATA 1.34E-05 CO 60 NO DATA 2.81E-06 6.33E-06 NO DATA NO DATA NO DATA 3.66E-05 NI 63 1.77E-04 1.25E-05 6.00E-06 NO DATA NO DATA NO DATA 1.99E-06 NI 65 7.49E-07 9.57E-08 4.36E-08 NO DATA NO DATA NO DATA 5.19E-07 CU 64 NO DATA 1.15E-07 5.41E-08 NO DATA 2.91E-07 NO DATA 8.92E-06 ZN 65 5.76E-06 2.00E-05 9.33E-06 NO DATA 1.28E-05 NO DATA 8.47E-06 ZN 69 1.47E-08 2.80E-08 1.96E-09 NO DATA 1.83E-08 NO DATA 5.16E-Or, BR 83 NO DATA NO DATA 5.74E-08 NO DATA NO DATA NO DATA LT E-24 BR 84 NO DATA NO DATA 7.22E-08 NO DATA NO DATA NO DATA LT E-24 BR 85 NO DATA NO DATA 3.05E-09 NO DATA NO DATA NO DATA LT E-24 RB 86 NO DATA 2.98E-05 1.40E-05 NO DATA NO DATA NO DATA 4.41E-06 RB 88 NO DATA 8.52E-08 4.54E-08 NO DATA NO DATA NO DATA 7.30E-15 RB 89 NO DATA 5.50E-08 3.89E-08 NO DATA NO DATA NO DATA 8.43E-17 SR 89 4.40E-04 NO DATA 1.26E-05 NO DATA NO DATA NO DATA 5.24E-05 SR 90 8.30E-03 NO DATA 2.05E-03 NO DATA NO DATA NO DATA 2.33E-04 SR 91 8.07E-06 NO DATA 3.21E-07 NO DATA NO DATA NO DATA 3.66E-05 SR 92 3.05E-06 NO DATA 1.30E-07 NO DATA NO DATA NO DATA 7.77E-05 Y 90 1.37E-08 NO DATA 3.69E-10 NO DATA NO DATA NO DATA 1.13E-04 Y 91M 1.29E-10 NO DATA 4.93E-12 NO DATA NO DATA NO DATA 6.09E-09 Y 91 2.01E-07 NO DATA 5.39E-09 NO DATA NO DATA NO DATA 8.24E-05 Y 92 1.21E-09 NO DATA 3.50E-11 NO DATA NO DATA NO DATA 3.32E-05

Taken from Regulatory Guide 1.109 (Rev. 1) l l

TABLE 3.1-3 (1 of 3)

j l

i TABLE 3.1-3 (cont'd)

(2 of 3)

INGESTION DOSE FACTORS FOR TEENAGER (MREM PER PCI INGESTED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI Y 93 3.83E-09 NO DATA 1.05E-10 NO DATA NO DATA NO DATA 1.17E-04 ZR 95 4.12E-08 1.30E-08 8.94E-09 NO DATA 1.91E-08 NO DATA 3.00E-05 ZR 97 2.37E-09 4.69E-10 2.16E-10 NO DATA 7.11E-10 NO DATA 1.27E-04 NB 95 8.22E-09 4.56E-09 2.51E-09 NO DATA 4.42E-09 NO DATA 1.95E-05 MO 99 NO DATA 6.03E-06 1.15E-06 NO DATA 1.38E-05 NO DATA 1.08E-05 TC 99M 3.32E-10 9.26E-10 1.20E-08 NO DATA 1.38E-08 5.14E-10 6.08E-07 TC101 3.60E-10 5.12E-10 5.03E-09 F0 DATA 9.26E-09 3.12E-1) 8.75E-18 RU103 2.55E-07 NO DATA 1.09E-07 NO DATA 8.99E-07 NO DATA 2.13E-05 RU105 2.18E-08 NO DATA 8.46E-09 NO DATA 2.75E-07 NO DATA 1.76E-05 RU106 3.92E-06 NO DATA 4.94E-07 NO DATA 7.56E-06 NO DATA 1.88E-04 AG110M 2.05E-07 1.94E-07 1.18E-07 NO DATA 3.70E-07 NO DATA 5.45E-05 TE125M 3.83E-06 1.38E-06 5.12E-07 1.07E-06 NO DATA NO DATA 1.13E-05 TE127M 9.67E-06 3.43E-06 1.15E-06 2.30E-06 3.92E-05 NO DATA 2.41E-05 TE127 1.58E-07 5.60E-08 3.40E-08 1.09E-07 6.40E-07 NO DATA 1.22E-05 TE129M 1.63E-05 6.05E-06 2.58E-06 5.26E-06 6.82E-05 NO DATA 6.12E-05 TE129 4.48E-08 1.67E-08 1.09E-08 3.20E-08 1.88E-07 NO DATA 2.45E-07 TE131M 2.44E-06 1.17E-06 9.76E-07 1.76E-06 1.22E-05 NO DATA 9.39E-05 TE131 2.79E-08 1.15E-08 8.72E-09 2.15E-08 1.22E-07 NO DATA 2.29E-09 TE132 3.49E-06 2.21E-06 2.08E-06 2.33E-06 2.12E-05 NO DATA 7.00E-05 I 130 1.03E-06 2.98E-06 1.19E-06 2.43E-04 4.59E-06 NO DATA 2.29E-06 I 131 5.85E-06 8.19E-06 4.40E-06 2.39E-03 1.41E-05 NO DATA 1.62E-06 I 132 2.79E-07 7.30E-07 2.62E-07 2.46E-05 1.15E-06 NO DATA 3.18E-07 I 133 2.01E-06 3.41E-06 1.04E-06 4.76E-04 5.98E-06 NO DATA 2.58E-06 I 134 1.46E-07 3.87E-07 1.39E-07 6.45E-06 6.10E-07 NO DATA 5.10E-09 I 135 6.10E-07 1.57E-06 5.82E-07 1.01E-04 2.48E-06 NO DATA 1.74E-06 CS134 8.37E-05 1.97E-04 9.14E-05 NO DATA 6.26E-05 2.39E-05 2.45E-06 CS136 8.59E-06 3.38E-05 2.27E-05 NO DATA 1.84E-05 2.90E-06 2.72E-06 CS137 1.12E-04 1.49E-04 5.19E-05 NO DATA 5.07E-05 1.97E-05 2.101 36 CS138 7.76E-08 1.49E-07 7.45E-08 NO DATA 1.10E-07 1.28E-08 6.76E-11 BA139 1.39E-07 9.78E-11 4.05E-09 NO DATA 9.22E-11 6.74E-11 1.24E-06 TABLE 3.1-3 (2 of 3)

TABLE 3.1-3 (cont'd)

(3 of 3)

INGESTION DOSE FACTORS FOR TEENAGER (MREM PER PCI INGESTED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI BA140 2.84E-05 3.48E-08 1.83E-06 NO DATA 1.18E-08 2.34E-08 4.38E-05 BA141 6.71E-08 5.01E-11 2.24E-08 NO DATA 4.65E-11 3.43E-11 1.*3E-13 BA142 2.99E-08 2.99E-11 1.84E-09 NO DATA 2.53E-11 1.99E-11 9.18E-20 LA140 3.48E-09 1.71E-09 4.55E-10 NO DATA NO DATA NO DATA 9.82E-05 LA142 1.79E-10 7.95E-11 1.98E-11 NO DATA NO DATA NO DATA 2.42E-06 CE141 1.33E-08 8.88E-09 1.02E-09 NO DATA 4.100-09 NO DATA 2.54E-05 CE143 2.35E-09 1.71E-06 1.91E-10 NO DATA 7.67E-10 NO DATA 5.14E-05 CD144 6.96E-07 2.88E-07 3.74E-08 NO DATA 1.72E-07 NO DATA 1.75E-04 PR143 1.31E-08 5.23E-09 6.5 2E-10 NO DATA 3.04E-09 NO DATA 4.31E-05 PR144 4.30E-11 1.76E-11 2.18E-12 NO DATA 1.01E-11 NO DATA 4.74E-14 ND147 9.38E-09 1.02E-08 6.11E-10 NO DATA 5.99E-39 NO DATA 3.68E-05 W 187 1.46E-07 1.19E-07 4.17E-C8 NO DATA NO DATA NO DATA 3.22E-05 NP239 1.76E-09 1.66E-10 9.22E-11 NO DATA 5.21E-10 NO DATA 2.67E-05 i

TABLE 3.1-3 i

(3 of 3) i l

l

~

TABLE 3.1-4*

(1 of 3)

INGESTION DOSE FACTORS FOR CHILD (MREM PER PCI INGESTED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H

3 NO DATA 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 2.03E-07 C 14 1.21E-05 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 2.42E-06 NA 24 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 5.80E-06 P 32 8.25E-04 3.86E-05 3.18E-05 NO DATA NO DATA NO DATA 2.28E-05 CR 51 NO DATA NO DATA 8.90E-09 4.94E-09 1.35E-09 9.02E-09 4.72E-07 MN 54 NO DATA 1.07E-05 2.85E-06 NO DATA 3.00E-06 NO DATA 8.98E-06 MN 56 NO DATA 3.34E-07 7.54E-08 NO DATA 4.04E-07 NO DATA 4.84E-05 FE 55 1.15E-05 6.10E-06 1.89E-06 NO DATA NO DATA 3.45E-06 1.13E-06 FE 59 1.65E-05 2.67E-05 1.33E-05 NO DATA NO DATA 7.74E-06 2.78E-05 CO 58 NO DATA 1.80E-06 5.51E-06 NO DATA NO DATA NO DATA 1.05E-05 CP 60 NO DATA 5.29E-06 1.56E-05 NO DATA NO DATA NO DATA 2.93E-05 NI 63 5.38E-04 2.88E-05 1.83E-05 NO DATA NO DATA NO DATA 1.94E-06 NI 65 2.22E-06 2.09E-07 1.22E-07 NO DATA NO DATA NO DATA 2.56E-05 CU 64 NO DATA 2.45E-07 1.48E-07 NO DATA 5.92E-07 NO DATA 1.15E-05 ZN 65 1.37E-05 3.65E-05 2.27E-05 NO DATA 2.30E-05 NO DATA 6.41E-06 ZN 69 4.38E-08 6.33E-08 5.85E-09 NO DATA 3.84E-08 NO DATA 3.99E-06 BR 83 NO DATA NO DATA 1.71E-07 NO DATA NO DATA NO DATA LT E-24 BR 84 NO DATA NO DATA 1.98E-07 NO DATA NO DATA NO DATA LT E-24 BR 85 NO DATA NO DATA 9.12E-09 NO DATA NO DATA NO DATA LT E-24 BR 86 NO DATA 6.70E-05 4.12E-05 NO DATA NO DATA NO DATA 4.31E-06 RB 88 NO DATA 1.90E-07 1.32E-07 NO DATA NO DATA NO DATA 9.32E-09 RB 89 NO DATA 1.17E-07 1.04E-07 NO DATA NO DATA NO DATA 1.02E-09 SR 89 1.32E-03 NO DATA 3.77E-05 NO DATA NO DATA NO DATA 5.11E-05 SR 90 1.70E-02 NO DATA 4.31E-03 NO DATA NO DATA NO DATA 2.29E-04 SR 91 2.40E-05 NO DATA 9.06E-07 NO DATA NO DATA NO DATA 5.30E-05 SR 92 9.03E-06 NO DATA 3.62E-07 NO DATA NO DATA NO DATA 1.71E-04 Y 90 4.11E-08 NO DATA 1.10E-09 NO DATA NO DATA NO DATA 1.17E-04 Y 91M 3.82E-10 NO DATA 1.39E-11 NO DATA NO DATA NO DATA 7.48E-07 Y 91 6.02E-07 NO DATA 1.61E-08 NO DATA NO DATA NO DATA 8.02E-05 Y 92 3.60E-09 NO DATA 1.03E-10 NO DATA NO DATA NO DATA 1.04E-04

Taken from Regulatory Guide 1.109 (Rev. 1).

TABLE 3.1-4 l

(1 of 3) 1

(

t

TABLE 3.1-4 (cott'd)

(2 of 3)

INGESTION DOSE FACTORS FOR CHILD (MREM PER PCI INGESTED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI Y 93 1.14E-08 NO DATA 3.13E-10 NO DATA NO DATA NO DATA 1.70E-04 ZR 95 1.16E-07 2.55E-08 2.27E-08 NO DATA 3.65E-08 NO DATA 2.66E-05 ZR 97 6.99E-09 1.01E-09 5.96E-10 NO DATA 1.45E-09 NO DATA 1.53E-04 NB 95 2.25E-08 8.76E-09 6.26E-09 NO DATA 8.23E-09 NO DATA 1.62E-05 MO 99 NO DATA 1.33E-05 3.29E-06 NO DATA 2.84E-05 NO DATA 1.10E-05 TC 99M 9.23E-10 1.81E-09 3.00E-08 NO DATA 2.63E-08 9.19E-10 1.03E-06 TC101 1.07E-09 1.12E-09 1.42E-08 NO DATA 1.91E-08 5.92E-10 3.56E-09 RU103 7.31E-07 NO DATA 2.81E-07 NO DATA 1.84E-06 NO DATA 1.89E-05 RU105 6.45E-08 NO DATA 2.34E-08 NO DATA 5.67E-07 NO DATA 4.21E-05 RU106 1.17E-05 NO DATA 1.46E-06 NO DATA 1.58E-05 NO DATA 1.82E-04 AG110M 5.39E-07 3.84E-07 2.91E-07 NO DATA 6.78E-07 NO DATA 4.33E-05 TE125M 1.14E-05 3.09E-06 1.52E-06 3.20E-06 NO DATA NO DATA 1.10E-05 TE127M 2.89E-05 7.78E-06 3.43E-06 6.91E-06 8.24E-05 NO DATA 2.34E-05 TE127 4.71E-07 1.27E-07 1.01E-07 3.26E-07 1.34E-06 NO DATA 1.84E-05 TE129M 4.87E-05 1.36E-05 7.56E-06 1.57E-05 1.43E-04 NO DATA 5.94E-05 TE129 1.34E-07 3.74E-08 3.18E-08 9.56E-08 3.92E-07 NO DATA 8.34E-06 TE131M 7.20E-06 2.49E-06 2.65E-06 5.12E-06 2.41E-05 NO DATA 1.01E-04 TE131 8.30E-08 2.53E-08 2.47E-08 6.35E-08 2.51E-07 NO DATA 4.36E-07 TE132 1.01E-05 4.47E-06 5.40E-06 6.51E-06 4.15E-05 NO DATA 4.50E-05 I 130 2.92E-06 5.90E-06 3.04E-06 6.50E-04 8.82E-06 NO DATA 2.76E-06 I 131 1.72E-05 1.73E-05 9.83E-06 5.72E-03 2.84E-05 NO DATA 1.54E-06 I 132 8.00E-07 1.47E-06 6.76E-07 6.82E-05 2.25E-06 NO DATA 1.73E-06 I 133 5.92E-06 7.32E-06 2.77E-06 1.36E-03 1.22E-05 NO DATA 2.95E-06 I 134 4.19E-07 7.78E-07 3.53E-07 1.79E-05 1.19E-06 NO DATA 5.16E-07 I 135 1.75E-06 3.15E-06 1.49E-06 2.79E-04 4.83E-06 NO D/TA 2.40E-06 CS134 2.34E-04 3.84E-04 8.10E-05 NO DATA 1.19E-04 4.27E-05 2.07E-06 CS136 2.35E-05 6.46E-05 4.18E-05 NO DATA 3.44E-05 5.13E-06 2.27E-06 CS137 3.27E-04 3.13E-04 4.62E-05 NO DATA 1.02E-04 3.67E-05 1.96E-06 CS138 2.28E-07 3.17E-07 2.01E-07 NO DATA 2.23E-07 2.40E-08 1.46E-07 BA139 4.14E-07 2.21E-10 1.20E-08 NO DATA 1.93E-10 1.30E-10 2.39E-05 TABLE 3.1-4 (2 of 3)

TABLE 3.1-4 (3 of 3)

INGESTION DOSE FACTORS FOR CHILD (MREM PER PCI INGESTED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI

~

BA140 8.31E-05 7.28E-08 4.85E-06 NO DATA 2.37E-08 4.34E-08 4.21E-05 BA141 2.00E-07 1.12E-10 6.51E-09 NO DATA 9.69E-11 6.58E-10 1.14E-07 BA142 8.74E-08 6.29E-11 4.88E-09 NO DATA 5.09E-11 3.70E-11 1.14E-09 LA140 1.01E-08 3.53E-09 1.19E-09 NO DATA NJ DATA NO DATA 9.84E-05 LA142 5.24E-10 1.67E-10 5.23E-11 NO DATA NO DATA NO DATA 3.31E-05 CE141 3.97E-08 1.98E-08 2.94E-09 NO DATA 8.68E-09 NO DATA 2.47E-05 CE143 6.99E-09 3.79E-06 5.49E-10 NO DATA 1.59E-09 NO DATA 5.55E-05 CE144 2.08E-06 6.52E-07 1.11E-07 NO DATA 3.61E-07 NO DATA 1.70E-04 PR143 3.93E-08 1.18E-08 1.95E-09 NO DATA 6.39E-09 NO DATA 4.24E-05 PR144 1.29E-10 3.99E-11 6.49E-12 NO DATA 2.11E-11 NO DATA 8.59E-08 4

ND147 2.79E-08 2.26E-08 1.75E-09 NO DATA 1.24E-08 NO DATA 3.58E-05 W 187 4.29E-07 2.54E-07 1.14E-07 NO DATA NO DATA NO DATA 3.57E-05 2

NP239 5.25E-09 3.77E-10 2.65E-10 NO DATA 1.09E-09 NO DATA 2.79E-05 s

TABLE 3.1-4 l

(3 of 3)

TABLE 3.1-5*

(1 of 3)

INGESTION DOSE FACTORS FOR INFANT (MREM PER PCI INGESTED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H

3 NO DATA 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08E-07 3.08E-07 C 14 2.37E-05 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 5.06E-06 NA 24 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 1.01E-05 P 32 1.70E-03 1.00E-04 6.59E-05 NO DATA NO DATA NO DATA 2.30E-05 CR 51 NO DATA NO DATA 1.41E-08 9.20E-09 2.01E-09 1.79E-08 4.11E-07 MN 54 NO DATA 1.99E-05 4.51E-06 NO DATA 4.41E-06 NO DATA 7 31E-06 MN 56 NO DATA 8.18E-07 1.41E-07 NO DATA 7.03E-07 NO DATA 7.43E-05 FE 55 1.39E-05 8.98E-06 2.40E-06 NO DATA NO DATA 4.39E-06 1.14E-06 FE 59 3.08E-05 5.38E-05 2.12E-05 NO DATA NO 7ATA 1.59E-05 2.57E-05 CO 58 NO DATA 3.60E-06 8.93E-06 NO DATA NO DATA NO DATA 8.97E-06 CO 60 NO DATA 1.08E-05 2.55E-05 NO DATA NO DATA NO DATA 2.57E-05 NI 63 6.34E-04 3.92E-05 2.20E-05 NO DATA NO DATA NO DATA 1.95E-06 NI 65 4.70E-06 5.32E-07 2.42E-07 NO DATn NO DATA NO DATA 4.05E-05 CU 64 NO DATA 6.09E-07 2.82E-07 NO DATA 1.03E-06 NO DATA 1.25E-05 ZN 65 1.84E-05 6.31E-05 2.91E-05 NO DATA 3.06E-05 NO DATA 5.33E-05 ZN 69 9.33E-08 1.68E-07 1.25E-08 NO DATA 6.98E-08 NO DATA 1.37E-05 BR 83 NO DATA NO DATA 3.63E-07 NO DATA NO DATA NO DATA LT E-24 BR 84 NO DATA NO DATA 3.82E-07 NO DATA NO DATA NO DATA LT E-24 BR 85 NO DATA NO DATA 1.94E-08 NO DATA NO DATA NO DATA LT E-24 RB 86 NO DATA 1.70E-04 8.40E-05 NO DATA NO DATA NO DATA 4.35E-06 RB 88 NO DATA 4.98E-07 2.73E-07 NO DATA NO DATA NO DATA 4.85E-07 RB 89 NO DATA 2.86E-07 1.97E-07 NO DATA NO DATA NO DATA 9.74E-08 SR 89 2.51E-03 NO DATA 7.20E-05 NO DATA NO DATA NO DATA 5.16E-05 SR 90 1.85E-02 NO DATA 4.71E-03 NO DATA NO DATA NO DATA 2.31E-04 SR 91 5.00E-05 NO DATA 1.81E-06 NO DATA NO DATA NO DATA 5.92E-05 SR 92 1.92E-05 NO DATA 7.13E-07 NO DATA NO DATA NO DATA 2.07E-04 3"

8.69E-08 NO DATA 2.33E-09 NO DATA NO DATA NO DATA 1.20E-04 Y 9'M 8.10E-10 NO DATA 2.76E-11 NO DATA NO DATA NO DATA 2.70E-06 Y 91 1.13E-06 NO DATA 3.01E-08 NO DATA NO DATA NO DATA 8.10E-05 Y 92 7.65E-09 NO DATA 2.15E-10 NO DATA NO DATA NO DATA 1.46E-04

Taken from Regulatory Guide 1.109 (Rev. 1)

TABLE 3.1-5 (1 of 3)

TABLE 3.1-5 (2 of 3)

INGESTION DOSE FACTORS FOR INFANT (MREM PER PCI INGESTED)

NUCLIDE BONE FIVER T. BODY TETROID KIDNEY LUNG GI-LLI Y 93 2.43E-08 NO DATA 6.62E-10 NO DATA NO DATA NO DATA 1.92E-04 ZR 95 2.06E-07 5.02E-08 3.56E-08 NO DATA 5.41E-08 NO DATA 2.50E-05 ZR 97 1.48E-08 2.54E-09 1.16E-09 NO DATA 2.56E-09 NO DATA 1.62E-04 NB 95 4.20E-08 1.73E-08 1.00E-08 NO DATA 1.24E-08 NO DATA 1.46E-05 MO 99 NO DATA 3.40E-05 6.63E-06 NO DATA 5.08E-05 NO DATA 1.12E-05 TC 99M 1.92E-09 3.96E-09 5.10E-08 NO DATA 4.26E-08 2.07E-09 1.15E-06 TC101 2.27E-09 2.86E-09 2.83E-08 NO DATA 3.40E-08 1.56E-09 4.86E-07 RU103 1.48E-06 NO DATA 4.95E-07 NO DATA 3.08E-06 NO DATA 1.80E-05 RU105 1.36E-07 NO DATA 4.58E-08 NO DATA 1.00E-06 NO DATA 5.41E-05 RU106 2.41E-05 NO DATA 3.01E-06 NO DATA 2.85E-05 NO DATA 1.83E-04 AG110M 9.96E-07 7.27E-07 4.81E-07 NO DATA 1.04E-06 NO DATA 3.77E-05 TE125M 2.33E-05 7.79E-06 3.15E-06 7.84E-06 NO DATA NO DATA 1.11E-05 TE127M 5.85E-05 1.94E-05 7.08E-06 1.69E-05 1.44E-04 NO DATA 2.36E-05 TE127 1.00E-06 3.35E-07 2.15E-07 8.14E-07 2.44E-06 NO DATA 2.10E-05 TE129M 1.00E-04 3.43E-05 1.54E-05 3.84E-05 2.50E-04 NO DATA 5.97E-05 TE129 2.84E-07 9.79E-08 6.63E-08 2.38E-07 7.07E-07 NO DATA 2.27E-05 TE131M 1.5 2E-05 6.12E-06 5.05E-06 1.24E-05 4.21E-05 1i0 DATA 1.03E-04 TE131 1.76E-07 6.50E-08 4.94E-08 1.57E-07 4.50E-07 NO DATA 7.11E-06 TE132 2.08E-05 1.03E-05 9.61E-06 1.52E-05 6.44E-05 NO DATA 3.81E-05 I 130 6.00E-06 1.32E-05 5.30E-06 1.48E-03 1.45E-05 NO DATA 2.83E-06 I 131 3.59E-05 4.23E-05 1.86E-05 1.39E-02 4.94E-05 NO DATA 1.51E-06 I 132 1.66E-06 3.37E-06 1.20E-06 1.58E-04 3.76E-07 NO DATA 2.73E-06 I 133 1.25E-05 1.82E-05 5.3?"-06 3.31E-03 2.14E-05 NO DATA 3.08E-06 I 134 8.69E-07 1.78E-06 6.324-07 4.15E-05 1.99E-06 NO DATA 1.84E-06 I 135 3.64E-06 7.24E-06 2.64E-06 6.49E-04 8.07E-06 NO DATA 2.62E-06 CS134 3.77E-04 7.03E-04 7.10E-05 NO DATA 1.81E-04 7.42E-05 1.91E-06 CS136 4.59E-05 1.35E-04 5.04E-05 NO DATA 5.38E-05 1.10E-05 2.05E-06 CS137 5.22E-04 6.11E-04 4.33E-05 NO DATA 1.64E-04 6.64E-05 1.91E-06 CS138 4.81E-07 7.82E-07 3.79E-07 NO DATA 3.90E-07 6.09E-08 1.25E-06 BA139 8.81E-07 5.84E-10 2.55E-08 NO DATA 3.51E-10 3.54E-10 5.58E-05 l

l l

TABLE 3.1-5 (2 of 3)

g-9 TABLE 3.1-5 (3 of 3)

INGESTION DOSE FACTORS FOR INFANT (MREM PER PCI INGESTED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI BA140 1.71E-04 1.71E-07 8.81E-06 NO DATA 4.06E-08 1.05E-07 4.20E-05 BA141 4.25E-07 2.91E-10 1.34E-08 NO DATA 1.75E-10 1.77E-10 5.19E-06 BA142 1.84E-07 1.53E-10 9.06E-09 NO DATA 8.81E-11 9.26E-11 7.59E-07 LA140 2.11E-08 8.32E-09 2.14E-09 NO DATA NO DATA NO DATA 9.77E-05 LA142 1.10E-09 4.04E-10 9.67E-11 NO DATA NO DATA NO DATA 6.86E-05 CE141 7.87E-08 4.80E-08 5 65E-09 NO DATA 1.48E-08 NO DATA 2.48E-05 CE143 1.48E-08 9.82E-06 1.12E-09 NO DATA 2.86E-09 NO DATA 5.73E-05 CE144 2.98E-06 1.22E-06 1.67E-07 NO DATA 4.93E-07 NO DATA 1.71E-04 PR143 8.13E-08 3.04E-08 4.03E-09 NO DATA 1.13E-08 NO DATA 4.29E-05 PR144 2.74E-10 1.06E-10 1.38E-11 NO DATA 3.84E-11 NO DATA 4.93E-06 ND147 5.53E-08 5.68E-08 3.48E-09 NO DATA-2.19E-08 NO DATA 3.60E-05 W 187 9.03E-07 6.28E-07 2.17E-07 NO DATA NO DATA NO DATA 3.69E-05 NP239 1.11E-08 9.93E-10 5.61E-10 NO DATA 1.98E-09 NO DATA 2.87E-05 1

i l

TABLE 3.1-5 (3 of 3) i t

TABLE 3.1-6*

(1 of 3)

INHALATION DOSE FACTORS FOR ADULTS (MREM PER PCI INHALED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H

3 NO DATA 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 1.58E-07 C 14 2.27E-06 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 4.26E-07 NA 24 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.28E-06 1.26E-06 1.28E-06 P 32 1.65E-04 9.64E-06 6.26E-06 NO DATA NO DATA NO DATA 1.08E-05 CR 51 NO DATA NO DATA 1.25E-08 7.44E-09 2.85E-09 1.80E-06 4.15E-07 MN 54 NO DATA 4.95E-06 7.87E-07 NO DATA 1.23E-06 1.75E-04 9.67E-06 MN 56 NO DATA 1.55E-10 2.29E-11 NO DATA 1.63E-10 1.18E-06 2.53E-06 FE 55 3.07E-06 2.12E-06 4.93E-07 NO DATA NO DATA 9.01E-06 7.54E-07 FE 59 1.47E-06 3.47E-06 1.32E-06 NO DATA NO DATA 1.27E-04 2.35E-05 CO 58 NO DATA 1.98E-07 2.59E-07 NO DATA NO DATA 1.16E-04 1.33E-05 CO 60 NO DATA 1.44E-06 1.85E-06 NO DATA NO DAT?.

7.46E-04 3.56E-05 NI 63 5.40E-05 3.93E-06 1.81E-06 NO DATA NO DATA 2.23E-05 1.67E-06 NI 65 1.92E-10 2.62E-11 1.14E-11 NO DATA NO DATA 7.00E-07 1.54E-06 CU 64 NO DATA 1.83E-10 7.69E-11 NO DATA 5.78E-10 8.48E-07 6.12E-06 ZN 65 4.05E-06 1.29E-05 5.82E-06 NO DATA 8.62E-06 1.08E-04 6.68E-06 ZN 69 4.23E-12 8.14E-12 5.65E-13 NO DATA 5.27E-12 1.15E-07 2.04E-09 BR 83 NO DATA NO DATA 3.01E-08 NO DATA NO DATA NO DATA 2.90E-08 BR 84 NO DATA NO DATA 3.91E-08 NO DATA NO DATA NO DATA 2.05E-13 BR 85 NO DATA NO DATA 1.60E-09 NO DATA NO DATA NO DATA LT E-24 RB 86 NO DATA 1.69E-05 7.37E-06 NO DATA NO DATA NO DATA 2.08E-06 RB 88 NO DATA 4.84E-08 2.41E-08 NO DATA NO DATA NO DATA 4.18E-19 RB 89 NO DATA 3.20E-08 2.12E-08 NO DATA NO DATA NO DATA 1.16E-21 SR 89 3.80E-05 NO DATA 1.09E-06 NO DATA NO DATA 1.75E-04 4.37E-05 SR 90 1.24E-02 NO DATA 7.62E-04 NO DATA NO DATA 1.20E-03 9.02E-05 SR 91 7.74E-09 NO DATA 3.13E-10 NO DATA NO DATA 4.56E-06 2.39E-05 SR 92 8.43E-10 NO DATA 3.64E-11 NO DATA NO DATA 2.06E-06 5.38E-06 Y 90 2.61E-07 NO DATA 7.01E-09 NO DATA NO DATA 2.12E-05 6.32E-05 Y 91M 3.26E-11 NO DATA 1.27E-12 NO DATA NO DATA 2.40E-07 1.66E-10 Y 91 5.78E-05 NO DATA 1.55E-06 NO DATA NO DATA 2.13E-04 4.81E-05 Y 92 1.29E-09 NO DATA 3.77E-11 NO DATA NO DATA 1.96E-06 9.19E-06

Taken from Regulatory Guide 1.109 (Rev. 1)

TABLE 3.1-6 (1 of 3)

TABLE 3.1-6 (2 of 3)

INHALF TON DOSE FACTORS FOR ADULTS (MREM PER PCI INHALED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LDiG GI-LLI Y 93 1.18E-08 NO DATA 3.26E-10 NO DATA NO DATA 6.06E-06 5.27E-05 ZR 95 1.34E-05 4.30E-06 2.91E-06 NO DATA 6.77E-06 2.21E-04 1.88E-05 ZR 97 1.21E-08 2.45E-09 1.13E-09 NO DATA 3.71E-09 9.84E-06 6.54E-05 NB 95 1.76E-06 9.77E-07 5.26E-07 NO DATA 9.67E-07 6.41E-05 1.30E-05 MO 99 NO DATA 1.51E-08 2.87E-09 NO DATA 3.64E-08 1.14E-05 3.10E-05 TC 99M 1.29E-13 3.64E-13 4.63E-12 NO DATA 5.52E-12 9.55E-08 5.20E-07 TC 101 5.22E-15 7.52E-15 7.38E-14 NO DATA 1.35E-13 4.99E-08 1.36E-21 RU 103 1.91E-07 NO DATA 8.23E-08 NO DATA 7.29E-07 6.31E-05 1.38E-05 RU 105 9.88E-11 NO DATA 3.89E-11 NO DATA 1.27E-10 1.37E-06 6.02E-06 RU 106 8.64E-06 NO DATA 1.09E-06 NO DATA 1.67E-05 1.17E-03 1.14E-04 AG 110M 1.35E-06 1.25E-06 7.43E-07 NO DATA 2.46E-06 5.79E-04 3.78E-05 TE 125M 4.27E-07 1.98E-07 5.84E-08 1.31E-07 1.55E-06 3.92E-05 8.83E-06 TE 127M 1.58E-06 7.21E-07 1.96E-07 4.11E-07 5.72E-06 1.20E-04 1.87E-05 TE 127 1.75E-10 8.03E-11 3.87E-11 1.32E-10 6.37E-10 8.14E-07 7.17E-06 TE 129M 1.22E-06 5.84E-07 1.98E-07 4.30E-07 4.57E-06 1.45E-04 4.79E-05 TE 129 6.22E-12 2.99E-12 1.55E-12 4.87E-12 2.34E-11 2.42E-07 1.96E-08 TE 131M 8.74E-09 5.45E-09 3.63E-09 6.88E-09 3.86E-08 1.82E-05 6.95E-05 TE 131 1.39E-12 7.44E-13 4.49E-13 1.17E-12 5.46E-12 1.74E-07 2.30E-09 TE 132 3.25E-08 2.69E-08 2.02E-08 2.37E-08 1.82E-07 3.60E-05 6.37E-05 I 130 5.72E-07 1.68E-06 6.60E-07 1.42E-04 2.61E-06 NO DATA 9.61E-07 I 131 3.15E-06 4.47E-06 2.56E-06 1.49E-03 7.66E-06 NO DATA 7.85E-07 I 132 1.45E-07 4.07E-07 1.45E-07 1.43E-05 6.48E-07 NO DATA 5.08E-08 I 133 1.08E-06 1.85E-06 5.65E-07 2.69E-04 3.23E-06 NO DATA 1.11E-06 I 134 8.05E-08 2.16E-07 7.69E-08 3.73E-06 3.44E-07 NO DATA 1.26E-10 I

135 3.35E-07 8.73E-O' 3.21E-07 5.60E-05 1.39E-06 NO DATA 6.56E-07 CS 134 4.66E-05 1.06E-04 9.10E-05 NO DATA 3.59E-05 1.22E-05 1.30E-06 CS 136 4.88E-06 1.83E-05 1.38E-05 NO DATA 1.07E-04 1.50E-06 1.46E-06 CS 137 5.98E-05 7.76E-05 5.35E-05 NO DATA 2.78E-05 9.40E-06 1.05E-06 CS 138 4.14E-08 7.76E-08 4.05E-08 NO DATA 6.00E-08 6.07E-09 2.33E-13 BA 139 1.17E-10 8.32E-14 3.42E-12 NO DATA 7.78E-14 4.70E-07 1.12E-07 TABLE 3.1-6 (2 of 3) l

--e%-.-

TABLE 3.1-6 (3 of 3)

INHALATION DOSE FACTORS FOR ADULTS (MREM PER PCI INHALED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI BA 140 4.88E-06 6.13E-09 3.21E-07 NO DATA 2.09E-09 1.59E-04 2.73E-05 BA 141 1.25E-11 9.14E-15 4.20E-13 NO DATA 8.75E-15 2.42E-07 1.45E-17 BA 142 3.29E-12 3.38E-15 2.07E-13 NO DATA 2.86E-15 1.49E-07 1.96E-26 LA 140 4.30E-08 2.17E-08 5.73E-09 NO DATA NO DATA 1.70E-05 5.73E-05 LA 142 8.54E-11 3.88E-11 9.65E-12 NO DATA NO DATA 7.91E-07 2.64E-07 CE 141 2.49E-06 1.69E-06 1.91E-07 NO DATA 7.83E-07 4.52E-05 1.50E-05 CE 143 2.33E-08 1.72E-08 1.91E-09 NO DATA 7.60E-09 9.97E-06 2.83E-05 CE 144 4.29E-04 1.79E-04 2.30E-05 NO DATA 1.06E-04 9.72E-04 1.02E-04 PR 143 1.17E-06 4.69E-07 5.80E-08 NO DATA 2.70E-07 3.51E-05 2.50E-05 PR 144 3.76E-12 1.56E-11 1.91E-13 NO DATA 8.81E-13 1.27E-07 2.69E-18 ND 147 6.59E-07 7.62E-07 4.56E-08 NO DATA 4.45E-07 2.76E-05 2.16E-05 W 187 1.06E-09 8.85E-10 3.10E-10 NO DATA NO DATA 3.63E-06 1.94E-05 NP 239 2.87E-08 2.32E-09 1.55E-09 NO DATA 8.75E-09 4.70E-06 1.49E-05 i

1 TABLE 3.1-6 (3 of 3)

TABLE 3.1-7*

(1 of 3)

INHALATION DOSE FACTORS FOR TEENAGER (MREM PER PCI INHALED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H

3 NO DATA 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 1.59E-07 C 14 3.25E-06 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 6.09E-07 NA 24 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 1.72E-06 P 32 2.36E-04 1.37E-05 8.95E-06 NO DATA NO DATA NO DATA 1.16E-05 CR 51 NO DATA NO DATA 1.69E-08 9.37E-09 3.84E-09 2.62E-06 3.75E-07 MN 54 NO DATA 6.39E-06 1.05E-06 NO DATA 1.59E-06 2.48E-04 8.35E-06 MN 56 NO DATA 2.12E-10 3.15E-11 NO DATA 2.24E-10 1.90E-06 7.18E-06 FE 55 4.18E-06 2.98E-06 6.93E-07 NO DATA NO DATA 1.55E-05 7.99E-07 FE 59 1.99E-06 4.62E-06 1.79E-06 NO DATA NO DATA 1.91E-04 2.23E-05 CO 58 NO DATA 2.59E-07 3.47E-07 NO DATA NO DATA 1.68E-04 1.19E-05 CO 60 NO DATA 1.89E-06 2.48E-06 NO DATA NO DATA 1.09E-03 3.24E-05 NI 63 7.25E-05 5.43E-06 2.47E-06 NO DATA NO DATA 3.84E-05 1.77E-06 NI 65 2.73E-10 3.66E-11 1.59E-11 NO DATA NO DATA 1.17E-06 4.59E-06 CU 64 NO DATA 2.54E-10 1.06E-10 NO DATA 8.01E-10 1.39E-06 7.68E-06 ZN 65 4.82E-06 1.67E-05 7.80E-06 NO DATA 1.08E-05 1.55E-04 5.83E-06 ZN 69 6.04E-12 1.15E-11 8.07E-13 NO DATA 7.53E-12 1.98E-07 3.56E-08 BR 63 NO DATA NO DATA 4.30E-08 NO DATA NO DATA NO DATA LT E-24 BR 84 NO DATA NO DATA 5.41E-08 NO DATA NO DATA NO DATA LT E-24 BR 85 NO DATA NO DATA 2.29E-09 NO DATA no DATA NO DATA LT E-24 RB 86 NO DATA 2.38E-05 1.05E-05 NO DATA NO DATA NO DATA 2.21E-06 RB 88 NO DATA 6.82E-08 3.40E-08 NO DATA NO DATA NO DATA 3.65E-15 RB 89 NO DATA 4.40E-08 2.91E-08 NO DATA NO DATA NO DATA 4.22E-17 SR 89 5.43E-05 NO DATA 1.56E-06 NO DATA NO DATA 3.02E-04 4.64E-05 SR 90 1.35E-02 NO DATA 8.35E-04 NO DATA NO DATA 2.06E-03 9.56E-05 SR 91 1.10E-08 NO DATA 4.39E-10 NO DATA NO DATA 7.59E-06 3.24E-05 SR 92 1.19E-09 NO DATA 5.08E-11 NO DATA NO DATA 3.43E-06 1.49E-05 Y 90 3.73E-07 NO DATA 1.00E-08 NO DATA NO DATA 3.66E-05 6.99E-05 Y 91M 4.63E-11 NO DATA 1.77E-12 NO DATA NO DATA 4.00E-07 3.77E-09 l

Y 91 8.26E-05 NO DATA 2.21E-06 NO DATA NO DATA 3.67E-04 5.11E-05 Y 92 1.84E-09 NO DATA 5.36E-11 NO DATA NO DATA

. 35E-06 2.06E-05

Taken from Regulatory Guide 1.109 (Rev. 1)

I TABLE 3.1-7 (1 of 3)

TABLE 3.1-7 (2 of 3)

INHALATION DOSE FACTORS FOR TEENAGER (MREM PER PCI INHALED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI Y 93 1.69E-08 NO DATA 4.65E-10 NO DATA NO DATA 1.04E-05 7.24E-05 ZR 95 1.82E-05 5.73E-06 3.94E-06 NO DATA 8.43E-06 3.36E-04 1.36E-05 ZR 97 1.72E-08 3.40E-09 1.57E-09 NO DATA 5.15E-09 1.62E-05 7.88E-05 NB 95 2.32E-06 1.29E-06 7.08E-07 NO DATA

1. 25E-Or, 9.39E-05 1.21E-05 MO 99 NO DATA 2.11E-08 4.03E-09 NO DATA 5.14E-08 1.92E-05 3.36E-05 TC 99M 1.73E-13 4.83E-13 6.24E-12 NO DATA 7.20E-12 1.44E-07 7.66E-07 TC 101 7.40E-15 1.05E-14 1.03E-13 NO DATA 1.90E-13 8.34E-08 1.09E-16 RU 103 2.63E-07 NO DATA 1.12E-07 NO DA'A 9.29E-07 9.79E-07 1.36E-05 RU 105 1.40E-10 NO DATA 5.42E-11 NO DATo 1.76E-10 2.27E-06 1.13E-05 RU 106 1.23E-u:

f0 DATA 1.55E-06 NO DATA 2.38E-05 2.01E-03 1.20E04 AG 110M 1.73E-06 1.64E-06 9.99E-07 NO DATA 3.13E-06 8.44E-04 3.41E-05 TE 125M 6.10E-07 2.80E-07 8.34E-08 1.75E-07 NO DATA 6.70E-05 9.38E-06 TE 127M 2.25E-06 1.02E-06 2.73E-07 5.48E-07 8.17E-06 2.07E-04 1.99E-05 TE 127 2.51E-10 1.14E-10 5.52E-11 1.77E-10 9.10E-10 1.40E-06 1.01E-05 TE 129M

.74E-06 8.23E-07 2.81Esa?

5.72E-07 6.49E-06 2.47E-04 5.06E-05 TE 129 8.87E-12 4.22E-12 2.20E-12 6.48E-12 3.32E-li 4.12E-07 2.02E-07 TE 131M 1.23E-08 7.51E-09 5.03E-09 9.06E-09 5.49E-08 2.97E-05 7.76E-05 TE 131 1.97E-12 1.04E-12 6.30E-13 1.55E-12 7.72E-12 2.92E-07 1.89E-09 TE 132 4.50E-08 3.63E-08 2.74E-08 3.07E-08 2.44E-07 5.61E-05 5.79E-05 I 130 7.80E-07 2.24E-06 8.96E-07 1.86E-04 3.44E-06 NO DATA 1.14E-06 I 131 4.43E-06 6.14E-06 3.30E-06 1.83E-03 1.05E-05 NO DATA 8.11E-07 r 132 1.99E-07 5.47E-07 1.97E-07 1.89E-05 8.65E-07 NO DATA 1.59E-07 I 133 1.52E-06 2.56E-06 7.78E-07 3.65E-04 4.49E-06 NO DATA 1.29E-06 I

134 1.11E-07 2.90E-07 1.05E-07

. 94E-06 4.58E-07 NO DATA 2.55E-09 I

135 4.62E-07 1.18E-06 4.36E-07 7.76E-05 1.86E-06 NO DATA 8.69E-07 CS 134 6.28E-05 1.41E-04 6.86E-05 NO DATA 4.69E-05 1.83E-05 1.22E-06 CS 136 6.44E-06 2.42E-05 1.71E-05 NO DATA 1.38E-05 2.22E-06 1.36E-06 CS 137 8.38E-05 1.06E-04 3.89E-05 NO DATA 3.80E-05 1.51E-05 1.06E-06 CS 138 5.82E-08 1.07E-07 5.58E-08 NO DATA 8.28E-08 9.84E-09 3.38E-11 BA 139 1.67E-10 1.18E-13 4.87E-12 NO DATA 1.11E-13 8.08E-07 8.06E-07 i

TABLE 3.1-7 (2 of 3) i

TABLE 3.1-7 (3 of 3)

INHALATION DOSE FACTORS FOR TEENAGER (MREM PER PCI INHALED)

NUCLIDE BONE LIVER T. BODY ICVROID KIDNEY LUNG GI-LLI BA 140 6.84E-06 8.38E-09 4.40E-07 NO DATA 2.85E-09 2.54E-04 2.86E-05 BA 141 1.78E-11 1.32E-14 5.93E-13 NO DATA 1.23E-14 4.11E-07 9.33E-14 BA 142 4.62E-12 4.63E 's 2.84E-13 NO DATA 3.91E-15 2.39E-07 5.99E-20 LA 140 5.99E-08 2.95E-08 7.82E-09 NO DATA NO DATA 2.68E-05 6.09E-05 LA 142 1.20E-10 5.31E-11 1.32E-11 NO DATA NO DATA 1.27E-06 1.50E-06 CE 141 3.55E-06 2.37E-06 2.71E-07 NO DATA 1.11E-06 7.67E-05 1.58E-05 CE 143 3.31E-08 2.42E-08 2.70E-09 NO DATA 1.08E-08 1.63E-05 3.19E-05 CE 144 6.11E-04 2.53E-04 3.28E-05 NO DATA 1.51E-04 1.67E-03 1.08E-04 PR 143 1.67E-06 6.64E-07 8.28E-08 NO DATA 3.86E-07 6.04E-05 2.67E-05 PR.144 5.37E-12 2.20E-12 2.72E-13 NO DATA 1.26E-12 2.19E-07 2.94E-14 ND 147 9.83E-07 1.07E-06 6.41E-08 NO DATA 6.28E-07 4.65E-05 2.28E-05 W 187 1.50E-09 1.22E-09 4.29E-10 NO DATA NO DATA 5.92E-06 2.21E-05 NP 239 4.23E-08 3.99E-09 2.?1E-09 NO DATA 1 25E-08 8.11E-06 1.65E-05 TABLE 3.1-7 (3 of 3)

TABLE 3.1-8*

(1 of 3)

INHALATION DOSE FACTORS FOR CHILD (MREM PER PCI INHALED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LLI H

3 NO DATA 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 3.04E-07 C 14 9.70E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 1.82E-06 NA 24 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-06 4.35E-05 4.35E-06 P 32 7.04E-04 3.09E-05 2.67E-05 NO DATA NO DATA NO DATA 1.14E-05 CR 51 NO DATA NO DATA 4.17E-08 2.31E-08 6.57E-09 4.59E-06 2.93E-07 MN 54 NO DATA 1.16E-05 2.57E-06 NO DATA

".71E-06 4.26E-04 6.19E-06 MN 56 NO DATA 4. 4',E-10 8.43E-11 NO DATA

4. 52E-10 3.55E-06 3.33E-05 FE 55 1.28E-05 6.t0E-06 2.10E-06 NO DATA NO DATA 3.00E-05 7.75E-07 FE 59 5.59E-06 9 04E-06 4.51E-06 NO DATA NO DATA 3.43E-04 1.91E-05 C0 58 NO DATA 4.79E-07 8.55E-07 NO DATA NO DATA 2.99E-04 9.29E-06 CO 60 NO DATA 3.55E-06 6.12E-06 NO DATA NO DATA 1.91E-03 2.60E-05 NI 63 2.22E-04 1.25E-05 7.56E-06 NO DATA NO DATA 7.43E-05 1.71E-06 NI 65 8.08E-10 7.99E-11 4.44E-11 NO DATA NO DATA 2.21E-06 2.27E-05 CU 64 NO DATA 5.39E-10 2.90E-10 NO DATA 1.63E-09 2.59E-06 9.92E-06 ZN 65 1.15E-05 3.06E-05 1.90E-05 NO DATA 1.93E-05 2.69E-04 4.41E-06 ZN 69 1.81E-11 2.61E-11 2.41E-12 NO DATA 1.58E-11 3.84E-07 2.75E-06 BR 83 NO DATA NO DATA 1.28E-07 NO DATA NO DATA NO DATA LT E-24 BR 84 NO DATA NO DATA 1.48E-07 NO DATA NO DATA NO DATA LT E-24 BR 85 NO DATA NO DATA 6.84E-09 NO DATA NO DATA NO DATA LT E-24 RB 86 NO DATA 5.36E-05 3.09E-05 NO DATA NO DATA NO DATA 2.16E-06 RB 88 NO DATA 1.52E-07 9.90E-08 NO DATA NO DATA NO DATA 4.66E-09 RB 89 NO DATA 9.33E-08 7.83E-08 NO DATA NO DATA NO DATA 5.11E-10 SR 89 1.62E-04 NO DATA 4.66E-06 NO DATA NO DATA 5.83E-04 4.52E-05 SR 90 2.73E-02 NO DATA 1.74E-03 NO DATA NO DATA 3.99E-03 9.28E-05 SR 91 3.28E-08 NO DATA 1.24E-09 NO DATA NO DATA 1.44E-05 4.70E-05 SR 92 3.54E-09 NO DATA 1.42E-10 NO DATA NO DATA 6.49E-06 6.55E-05 Y 90 1.11E-06 NO DATA 2.99E-08 NO DATA NO DATA 7.07E-05 7.24E-05 Y 91M 1.37E-10 NO DATA 4.98E-12 NO DATA NO DATA 7.60E-07 4.64E-07 Y 91 2.47E-04 NO DATA 6.59E-06 NO DATA NO DATA 7.10E-04 4.97E-05 Y 92 5.50E-09 NO DATA 1.57E-10 NO DATA NO DATA 6.46E-06 6.46E-05

Taken From Regulatory Guide 1.109 (Rev. 1)

TABLE 3.1-8 (1 of 3)

TABLE 3.1-8 (2 of 3)

INHALATION DOSE FACTORS FOR CHILD (MREM PER PCI INHALED)

NUCLIDE BONE LIVER T.B0DY THYROID KIDNEY LUNG GI-LLI Y 93 5.04E-08 NO DATA 1.38E-09 NO DATA NO DATA 2.01E-C5 1.05E-04 ZR 95 5.13E-05 1.13E-05 1.00E-05 NO DATA 1.61E-05 6.03E-04 1.65E-05 ZR 97 5.07E-08 7.34E-09 4.32E-09 NO DATA 1.05E-08 3.06E-05 9.49E-05 NB 95 6.35E-06 2.48E-06 1.77E-06 NO DATA 2.33E-06 1.66E-04 1.00E-05 MO 99 NO DATA 4.66E-08 1.15E-08 NO DATA 1.06E-07 3.66E-05 3.42E-05 TC 99M 4.81E-13 9.41E-13 1.56E-11 NO DATA 1.37E-11 2.57E-07 1.30E-06 TC101 2.19E-14 2.30E-14 2.91E-13 NO DATA 3.92E-13 1.58E-07 4.41E-09 RU103 7.55E-07 NO DATA 2.90E-07 NO DATA 1.90E-06 1.79E-04 1.21E-05 RU105 4.13E-10 NO DATA 1.50E-10 NO DATA 3.63E-10 4.30E-06 2.69E-05 RU106 3.68E-05 NO DATA 4.57E-06 NO DATA 4.97E-05 3.87E-03 1.16E-04 AG110M 4.56E-06 3.08E-06 2.47E-06 NO DATA 5.74E-06 1.48E-03 2.71E-05 TE125M 1.82E-06 6.29E-07 2.47E-07 5.20E-07 NO DATA 1.29E-04 9.13E-06 TE127M 6.72E-06 2.31E-06 8.16E-07 1.64E-06 1.72E-05 4.00E-04 1.93E-05 TE127 7.49E-10 2.57E-10 1.65E-10 5.30E-10 1.91E-09 2.71E-06 1.52E-05 TE129M 5.19E-06 1.85E-06 8.22E-07 1.71E-06 1.36E-05 4.76E-04 4.91E-05 TE129 2.64E-11 9.45E-12 6.44E-12 1.93E-11 6.94E-11 7.93E-07 6.89E-06 TE131M 3.63E-08 1.60E-08 1.37E-08 2.64E-08 1.08E-07 5.56E-05 8.32E-05 TE131 5.87E-12 2.28E-12 1.78E-12 4.59E-12 1.59E-11 5.55E-07 3.60E-07 TE132 1.30E-07 7.36E-08 7.12E-08 8.58E-08 4.79E-07 1.02E-04 3.72E-05 I 130 2.21E-06 4.43E-06 2.28E-06 4.99E-04 6.61E-06 NO DATA 1.38E-06 I 131 1.30E-05 1.30E-05 7.37E-06 4.39E-03 2.13E-05 NO DATA 7.68E-07 I 132 5.72E-07 1.10E-06 5.07E-07 5.23E-05 1.69E-06 NO DATA 8.65E-07 I 133 4.48E-06 5.49E-06 2.08E-06 1.04E-03 9.13E-06 NO DATA

?.48E-06 I 134 3.17E-07 5.64E-07 2.69E-07 1.37E-05 8.92E-07 NO DATA 2.58E-07 I 135 1.33E-06 2.36E-06 1.12E-06 2.14E-04 3.62E-06 NO DATA 1.20E-06 CS134 1.76E-04 2.74E-04 6.07E-05 NO DATA 8.93E-05 3.27E-05 1.04E-06 CS136 1.76E-05 4.62E-05 3.14E-05 NO DATA 2.58E-05 3.93E-06 1.13E-06 CS137 2.45E-04 2.23E-04 3.47E-05 NO DATA 7.63E-05 2.81E-05 9.78E-07 CS138 1.71E-07 2.27E-07 1.50E-07 NO DATA 1.68E-07 1.84E-08 7.29E-08 BA139 4.98E-10 2.66E-13 1.45E-11 NO DATA 2.33E-13 1.56E-06 1.56E-05 TABLE 3.1-8

[

(2 of 3) l

TABLE 3.1-8 (3 of 3)

INHALATION DOSE FACTORS FOR CHILD (MREM PER PCI INHALED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LII BA140 2.00E-05 1.75E-08 1.17E-06 NO DATA 5.71E-09 4.71E-04 2.75E-05 BA141 5.29E-11 2.95E-14 1.72E-12 NO DATA 2.56E-14 7.89E-07 7.44E-08 BA142 1.35E-11 9.73E-15 7.54E-13 NO DATA 7.87E-15 4.44E-07 7.41E-10 LA140 1.74E-07 6.08E-08 2.04E-08 NO DATA NO DATA 4.94E-05 6.10E-05 LA142 3.50E-10 1.11E-10 3.49E-11 NO DATA NO DATA 2.35E-06 2.05E-05 CE141 1.06E-05 5.28E-06 7.83E-07 NO DATA 2.31E-06 1.47E-04 1.53E-05 CE143 9.89E-08 5.37E-08 7.77E-09 NO DATA 2.26E-08 3.12E-05 3.44E-05 CE144 1.83E-03 5.72E-04 9.77E-05 NO DATA 3.17E-04 3.23E-03 1.05E-04 PR143 4.99E-06 1.50E-06 2.47E-07 NO DATA 8.11E-07 1.17E-04 2.63E-05 PR144 1.61E-11 4.99E-12 8.10E-13 NO DATA 2.64E-12 4.23E-07 5.32E-08 ND147 2.92E-06 2.36E-06 1.84E-07 NO DATA 1.30E-06 8.87E-05 2.22E-05 W 187 4.42E-09 2.61E-09 1.17E-09 NO DATA NO DATA 1.11E-05 2.46E-05 NP239 1.26E-07 9.04E-09 6.35E-09 NO DATA 2.63E-08 1.57E-05 1.73E-05 TABLE 3.1-8 l

(3 of 3) l

TABLE 3.1-9*

(1 of 3)

INHALATION DOSE FACTORS FOR IhTANT (MREM PER PCI INHALED)

UCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LII H

3 NO DATA 4.62E-07 4.62E-07 3.62E-07 4.62E-07 4.62E-07 4.62E-07 C 14 1.89E-05 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 3.79E-06 NA 24 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 7.54E-06 P 32 1.45E-03 8.03E-05 5.53E-05 NO DATA NO DATA NO DATA 1.15E-05 CR 51 NO DATA NO DATA 6.39E-08 4.11E-08 9.45E-09 9.17E-06 2.55E-07 MN 54 NO DATA 1.81E-05 3.56E-06 NO DATA 3.56E-06 7.14E-04 5.04E-06 MN 56 NO DATA 1.10E-09 1.58E-10 NO DATA 7.86E-10 8.95E-06 5.12E-05 FE 55 1.41E-05 8.39E-06 2.38E-06 NO DATA NO DATA 6.21E-05 7.82E-07 FE 59 9.69E-06 1.68E-05 6.77E-06 NO DATA NO DATA 7.25E-04 1.77E-05 CO 58 NO DATA 6.71E-07 1.30E-06 NO DATA NO DATA 5.55E-04 7.95E-06 CO 60 NO DATA 5.73E-06 8.41E-06 NO DATA NO DATA 3.22E-03 2.28E-05 NI 63 2.42E-04 1.46E-05 8.29E-06 NO DATA NO DATA 1.49E-04 1.73E-06 NI 65 1.7 "-09 2.03E-10 8.79E-11 NO DATA NO DATA 5.80E-06 3.58E-05 CO 64 NO

. A 1.34E-09 5.53E-10 NO DATA 2.84E-09 6.64E-06 1.07E-05 ZN 65 1.3bE-05 4.47E-05 2.22E-05 NO DATA 2.32E-05 4.62E-04 3.67E-05 ZN 69 3.85E-11 6.91E-11 5.13E-12 NO DATA 2.87E-11 1.05E-06 9.44E-06 BR 83 NO DATA NO DATA 2.72E-07 NO DATA NO DATA NO DATA LT E-24 BR 84 NO DATA NO DATA 2.86E-07 NO DATA NO DATA NO DATA LT E-24 BR 85 NO DATA NO DATA 1.46E-08 NO DATA NO DATA NO DATA LT E-24 RB 86 NO DATA 1.36E-04 6.30E-05 NO DATA NO DATA NO DATA 2.17E-06 RB 88 NO DATA 3.98E-07 2.05E-07 NO DATA NO DATA NO DATA 2.42E-07 RB 89 NO DATA 2.29E-07 1.47E-07 NO DATA NO DATA NO DATA 4.87E-08 SR 89 2.84E-04 NO DATA 8.15E-06 NO DATA NO DATA 1.45E-03 4.57E-05 SR 90 2.92E-02 NO DATA 1.85E-03 "O DATA NO DATA 8.03E-03 9.36E-05 SR 91 6.83E-08 NO DATA 2.47E-09 hkIDATA NO DATA 3.76E-05 5.24E-05 SR 92 7.50E-09 NO DATA 2.79E-10 NO DATA NO DATA 1.70E-05 1.00E-04 Y 90 2.35E-06 NO DATA 6.30E-08 NO DATA NO DATA 1.92E-04 7.43E-05 Y 91M 2.91E-10 NO DATA 9.90E-12 NO DATA NO DATA 1.99E-06 1.68E-06 Y 91 4.20E-04 NO DATA 1.12E-05 NO DATA NO DATA 1.75E-03 5.02E-05 Y 92 1.17E-08 NO DATA 3.29E-10 NO DATA NO DATA 1.75E-05 9.04E-05 i

l i

Taken from Regulatory Guide 1.109 (Rev. 1)

TABLE 3.1-9 (1 of 3)

TABLE 3.1-9 (2 of 3)

INHALATION DOSE FACTORS FOR INFANT (MREM PER PCI INHALED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LII Y 93 1.07E-07 NO DATA 2.91E-09 NO DATA NO DATA 5.46E-05 1.19E-04 ZR 95 8.24E-05 1.99E-05 1.45E-05 NO DATA 2.22E-05 1.25E-03 1.55E-05 ZR 97 1.07E-07 1.83E-08 8.36E-09 NO DATA 1.85E-08 7.88E-05 1.00E-04 l

NB 95 1.12E-05 4.59E-06 2.70E-06 NO DATA 3.37E-06 3.42E-04 9.05E-06 MO 99 NO DATA 1.18E-07 2.31E-08 NO DATA 1.89E-07 9.63E-05 3.48E-05 TC 99M 9.98E-13 2.06E-12 2.66E-11 NO DATA 2.22E-11 5.79E-07 1.45E-06 TC101 4.65E-14 5.88E-14 5.80E-13 NO DATA 6.99E-13 4.17E-07 6.03E-07 RU103 1.44E-06 NO DATA 4.85E-07 NO DATA 3.03E-06 3.94E-04 1.15E-05 RU105 8.74E-10 NO DATA 2.93E-10 NO DATA 6.42E-10 1.12E-05 3.46E-05 RU106 6.20E-05 NO DATA 7.77E-06 NO DATA 7.61E-05 8.26E-03 1.17E-04 AG110M 7.13E-06 5.16E-06 3.57E-06 NO DATA 7.80E-06 2.62E-03 2.36E-05 TE125M 3.40E-06 1.42E-06 4.70E-07 1.16E-06 NO DATA 3.19E-04 9.22E-06 l

l TE127M 1.19E-05 4.93E-06 1.48E-06 3.48E-06 2.68E-05 9.37E-04 1.95E-05 j

TE127 1.59E-09 6.81E-10 3.49E-10 1.32E-09 3.47E-09 7.39E-06 1.74E-05 TE129M 1.01E-05 4.35E-06 1.59E-06 3.91E-06 2.27E-05 1.20E-03 4.93E-05 l

TE129 5.63E-11 2.48E 11 1.34E-11 4.82E-11 1.25E-10 2.14E-06 1.88E-05 l

TE131M 7.62E-08 3.93E-08 2.59E-08 6.38E-08 1.89E-07 1.42E-04 8.51E-05 l

TE131 1.24E-11 5.87E-12 3.57E-12 1.13E-11 2.85E-11 1.47E-06 5.87E-06 TE132 2.66E-07 1.69E-07 1.26E-07 1.99E-07 7.39E-07 2.43E-04 3.15E-05 I 130 4.54E-06 9.91E-06 3.98E-06 1.14E-03 1.09E-05 NO DATA 1.42E-06 I 131 2.71E-05 3.17E-05 1.40E-05 1.06E-02 3.70E-05 NO DATA 7.56E-07 I 132 1.21E-06 2.53E-06 8.99E-07 1.21E-04 2.82E-06 NO DATA 1.36E-06 I 133 9.46E-06 1.37E-05 4.00E-06 2.54E-03 1.60E-05 NO DATA 1.54E-06 j

I 134 6.58E-07 1.34E-06 4.75E-07 3.18E-05 1.49E-06 NO DATA 9.21E-07 I 135 2.76E-06 5.43E-06 1.98E-06 4.97E-04 6.05E-06 NO DATA 1.31E-06 CS134 2.83E-04 5.02E-04 5.32E-05 NO DATA 1.36E-04 5.69E-05 9.53E-07 CS136 3.45E-05 9.61E-05 3.78E-05 NO DATA 4.03E-05 8.40E-06 1.02E-06 l

l CS137 3.92E-04 4.37E-04 3.2SE-05 NO DATA 1.23E-04 5.09E-05 9.53E-07 CS138 3.61E-07 5.58E-07 2.84E-07 NO DATA 2.93E-07 4.67E-08 6.26E-07 l

BA139 1.06E-09 7.03E-13 3.07E-11 NO DATA 4.23E-13 4.2SE-06 3.64E-05 l

l l

TABLE 3.1-9 (2 of 3)

TABLE 3.1-9 (3 of 3)

INHALATION DOSE FACTORS FOR INFANT (MREM PER PCI INHALED)

NUCLIDE BONE LIVER T. BODY THYROID KIDNEY LUNG GI-LII BA140 4.00E-05 4.00E-08 2.07E-06 NO DATA 9.59E-09 1.14E-03 2.74E-05 BA141 1.12E-10 7.70E-14 3.55E-12 NO DATA 4.64E-14 2.12E-06 3.39E-06 BA142 2.84E-11 2.36E-14 1.40E-12 NO DATA 1.36E-14 1.11E-06 4.95E-07 i

LA140 3.61E-07 1.432-07 3.68E-08 NO DATA NO DATA 1.20E-04 6.06E-05 LA142 7.36E-10 2.69E-10 6.46E-11 NO DATA NO DATA 5.87E-06 4.25E-05 CE141 1.98E-05 1.19E-05 1.42E-06 NO DATA 3.75E-06 3.69E-04 1.54E-05 CE143 2.98E-07 1.38E-07 1.58E-08 NO DATA 4.03E-08 8.30E-05 3.55E-05 i

CE144 2.28E-03 8.65E-04 1.26E-04 NO DATA 3.84E-04 7.03E-03 1.06E-04 i

PR143 1.00E-05 3.74E-06 4.99E-07 NO DATA 1.41E-06 3.09E-04 2.66E-05 PR144 3.42E-11 1.32E-11 1.72E-12 NO DATA 4.80E-12 1.15E-06 3.06E-06 ND147 5.67E-06 5.81E-06 3.57E-07 NO DATA 2.25E*06 2.30E-04 2.23E-05 W 187 9.26E-09 6.44E-09 2.23E-09 NO DATA NO DATA 2.83E-05 2.54E-05 NP239 2.65E-07 2.37E-08 1.34E-08 NO DATA 4.73E-08 4.25E-05 1.78E-05 i

I l

l TABLE 3.1-9 (3 of 3)

}

TABLE 3.1-10*

(16f 2)

EXTERNAL DOSE FACTORS FOR STANDING ON CONTAMINATED GROUND 2

(arem/hr per pCi/m )

I Element Total Body Skin H-3 0.0 0.0 C-14 0.0 0.0 l

NA-24 2.50E-08 2.90E-08 P-32 0.0 0.0 Cr-51 2.20E-10 2.60E-10 Mn-54 5.80E-09 6.80E-09 Mn-56 1.10E-08 1.30E-08 Fc-55 0.0 0.0 Fe-59 8.00E-09 9.40E-09 Co-58 7.00E-09 8.20E-09 Co-60 1.70E-08 2.00E-08 Ni-63 0.0 0.0 Nr-65 3.70E-09 4.30E-09 i

Cu-64 1.50E-09 1.70E-09 Zn-65 4.00E-09 4.60E-09 Zn-69 0.0 0.0 Br-83 6.40E-11 9.30E-11 Br-84 1.20E-08 1.40E-08 Br-85 0.0 0.0 Rb-86 6.30E-10 7.20E-10 Rb-88 3.50E-09 4.00E-09 Rb-89 1.50E-08 1.80E-08 Sr-89 5.60E-13 6.50E-13 Sr-91 7.10E-09 8.30E-09 i

Sr-92 9.00E-09 1.00E-08 Y-90 2.20E-12 2.60E-12 Y-91M 3.80E-09 4.40E-09 Y-91 2.40E-11 2.70E-11 Y-92 1.60E-09 1.90E-09 Y-93 5.70E-10 7.80E-10 Zr-95 5.00E-09 5.80E-09 Zr-97 5.50E-09 6.40E-09 Nb-95 5.10E-09 6.00E-09 Mo-99 1.90E-09 2.20E-09 Tc-99M 9.60E-10 1.10E-09 Tc-101 2.70E-09 3.00E-09 Ru-103 3.60E-09 4.20E-09 Ru-105 4.50E-09 5.10E-09 Ru-106 1.50E-09 1.80E-09 Ag-110M 1.80E-08 2.10E-08 Te-125M 3.50E-11 4.80E-11 Te-127M 1.10E-12 1.30E-12 Te-127 1.00E-11 1.10E-11 Te-129M 7.70E-10 9.00E-10 Te-129 7.10E-10 8.40E-10

Taken from Regulatory Guide 1.109 (Rev. 1)

TABLE 3.1-10 (1 of 2)

TABLE 3.1-10 (2 of 2)

EXTERNAL DOSE FACTORS FOR STANDING ON CONTAMINATED GROUND 2

(mrem /hr per pCi/m )

Element Total Body Skin Te-131M 8.40E-09 9.90E-09 Te-131 2.20E-09 2.60E-06 Te-132 1.70E-09 2.00E-09 I-130 1.40E-08 1.70E-08 I-131 2.80E-09 3.40E-09 I-132 1.70E-08 2.00E-08 I-133 3.70E-09 4.50E-09 I-134 1.60E-08 1.90E-08 I-135 1.20E-08 1.40E-08 Cs-134 1.20E-08 1.40E-08 Cs-136 1.50E-08 1.70E-08 Cs-137 4.20E-09 4.90E-09 Cs-138 2.10E-08 2.40E-08 Ba-139 2.40E-09 2.70E-09 Ba-140 2.10E-09 2.40E-09 Ba-141 4.30E-09 4.90E-09 Ba-142 7.90E-09 9.00E-09 La-140 1.50E-08 1.70E-08 La-142 1.50E-08 1.80E-08 Ce-141 5.50E-10 6.20E-10 Ce-143 2.20E-09 2.50E-09 Ce-144 3.20E-10 3.70E-10 Pr-143 0.0 0.0 Pr-144 2.00E-10 2.30E-10 Nd-147 1.00E-09 1.20E-09 W-187 3.10E-09 3.60E-09 Np-239 9.50E-10 1.10E-09 Table 3.1-10 (2 of 2)

TABLE 3.1-11*

(1 of 1)

STABLE ELEMENT TRANSFER DATA F,(Cow)

F f Element Milk (d/2)

Meat (d/kg)

H 1.0E-02 1.2E-02 C

1.2E-02 3.1E-02 Na 4.0E-02 3.0E-02 P

2.5E-02 4.6E-02 Cr 2.2E-03 2.4E-03 Mn 2.5E-04 8.0E-04 Fe 1.2E-03 4.C2-02 Co 1.0E-03 1.3E-02 Ni 6.7E-03 5.3E-02 Cu 1.4E-02 8.0E-03 Zn 3.9E-02 3.0E-02 Rb 3.0E-02 3.1E-02 Sr 8.0E-04 6.0E-04 Y

1.0E-05 4.6E-03 Zr 5.0E-06 3.4E-02 Nb 2.5E-03 2.8E-01 Mo 7.5E-03 8.0E-03 Tc 2.5E-02 4.0E-01 Ru 1.0E-06 4.0E-01 Rh 1.0E-02 1.5E-03 Ag 5.0E-02 1.7E-02 Te 1.0E-00 7.7E-02 I

6.0E-03 2.9E-03 Cs 1.2E-02 4.0E-03 Ba 4.0E-04 3.2E-03 La 5.0E-06 2.0E-04 Ce 1.0E-04 1.2E-03 Pr 5.0E-06 4.7E-03 Nd 5.0E-06 3.3E-03 W

5.0E-04 1.3E-03 i

Np 5.0E-06 2.0E-04

Taken from Regulatory Guide 1.109 (Rev. 1)

+F, for goat is 6.0E-2.

TABLE 3.1-11 (1 of 1) i f

e 0

6 APPENDIX B MCGUIRE NUCLEAR STATION SITE SPECIFIC INFORMATION l

..},

9,,

h J

i 6-

)

APPENDIX B - TABLE OF CONTENTS Page Bl.0 MCGUIRE NUCLEAR STATION RADWASTE SYSTEMS b-1 B2.0 RELEASE RATE CALCULATION B-4 4

B3.0 RADIATION MONITOR SETPOINTS B-8 B4.0 DOSE CALCULATIONS B-10 B5.0 RADIOLOGICAL ENVIRONMENTAL MONITORING B-13 l

j

.l l

i i

t I

-.- - -.~..., --, -. -..

o-I T

o gi j a

-i a

L i-

=

(!

j

{

,f' ij O <--

El

~

-r0 s

i

-11 i

s s

-k-E 11

=l f

ig, H'['['1j-Ph"-[

i*

Q--

E g;g (y

il y

a

.=

til o

=

.r F

...J 3

=

3 g

[

s. g 5g b

l yll

,.g

, --L,g Mit Wai v E.

s.ni g

~ 1,.' '

it' 8

n M

M V

O la a

l-3j

.=

a I

"1 r

_a gjSj

. ),=J g

si!

i;

"'s e

I* I b

I s

I t

1, FIGi'RE 31.^ i r

ti of 1)

, ~.

Bl.2 GASEOUS RADWASTE SYSTEMS The gaseous waste disposal system for McGuire is designed with the capability of processing the fission product gases from contaminated reactor coolant fluids resulting from operation. The system shown schematically in Fig. Bl.0-2 is designed to allow for the retention, through the plant lifetime, of all the gaseous fission products to be discharged from the reactor coolant system to the chemical and volume control system or the boron recycle system, to elimi-nate the need for intentional discharge of radioactive gases from the waste gas holdup tanks. Thus, the only unavoidable sources of low-level radioactive gaseous discharge to the environment will be from periodic purging operations of the containment, from the auxiliary building ventilation system, and through the secondary system air ejector. With respect to the former, the potential contamination is expected to arise from uncollectable reactor coolant leakage.

With respect to the air ejector, the potential source of contamination will be from leakage of the reactor coolant to the secondary system through defects in steam generator tubes. The gaseous waste disposal system includes two waste gas compressors, two catalytic hydrogen recombiners, six gas decay storage tanks for use during normal power generation, and two gas decay storage tanks for use during shutdown and startup operations.

Bl.2.1 Gas Collection System The gas collection system combines the waste hydrogen and fission gases from the volume control tanks and that from the boron recycle gas stripper evaporator produced during normal operation with the gas collected during the shutdown degasification (high percentage of nitrogen) and will cycle it through the catalytic recombiners to convert all the hydrogen to water. After the water vapor is removed, the resulting gas stream will be transferred from the recom-biner into the gas decay tanks, where the accumulated activity may be contain.d in six approximately equal parts. From the decay tanks the gas will flow back to the compressor suction to complete the loop circuit.

Bl.2.2 Containment and Auxiliary Building Ventilation Nonrecyclable reactor coolant leakage occurring either inside the containment or inside the auxiliary building will generate gass 'us activity.

Gases result-ing from leakage inside the containment will be c atained until the containment is purged. The containment atmosphere will be circulated through a charcoal adsorber and a particulate filter prior to release to the atmosphere.

Gases resulting from leakage inside the auxiliary building are released, with-out further decay, to the atmosphere via the auxiliary building ventilation system. The ventilation exhaust from potentially contaminated areas in the auxiliary building is passed through charcoal adsorbers to reduce releases to the atmosphere.

Bl.2.3 Secondary Systems l

When activity is in the secondary system, steam generator blowdown will be recycled through demineralizers to remove activity and the liquids will be removed by the ejector condenser prior to discharge to the unit vent.

l B-2

ROOF VENTS 489.000 cfm

__ _ t

_ex _ _,

M OUT, SIDE

~~~

W" OUTSIDE AIR __

f

,x AR TURBINE

y i

m i

PRIMARY l

CONDENSER I

k l

COOLANT cENEa ATOa ( ) e _ _ _ _ _ _ _ _ _._ _V_ _ _ _ ;g STEAM g

=NoENSER n

STE M ET AIR TURB8NE SUILDING R

TSON TO CONDENSER wtTH MONITOR o_wlf viny 142 F T SAFFLES ABOVE BLOWOOwN q

A GROUND RECYCLE M

TANK R ADI ATION ~

Q SECONDARY SYSTEM (2 UNITS)

MONITOR LETDOWN FLOW FROM REACTOR COOLANT SYSTEM -

(2) HYDROGEN RECOMBINERS WASTE GAS g a

g COMPRESSORS,

IOXYGEN WATERg (2 - UNITS)

I

[*~2

[*( }

VOLUME l

TO

~ "2 VOLUME ONiRCL g

CONTROL TANK s / \\\\

/p q%

VOLUME SHUTOOWN ygqg UNIT 1 s

STORAGE TANKS I

CONTROL TANK UNIT 2 1*- PLANT l

y y

Y yi VENT I

k a._I STACK 1

j

_____________________________a TO REACTOR

TO RE ACTOR =

A A A A A A

CAS GAS TANKS 3

BORON RECVCLE STORAGE 600 FT SHIM 8LE E D TANKS 130 Pug EVAPORATOR GAS STRIPPER WASTE GAS SYSTEM ONTAINME CONTAlNMENT UPPER VOLUME NORMALLY CLOSED A 0 LOWER VOLUME p

PURGE OUTLET PURCEINLET C

A P or

_m.

~*~

9,400 cfm CONTAINMENT VENTILATION SYSTEMS (2)

INTERNAff0NAL RECIRCULATING TRAINS (2) 8.000 cfm EACH FUEL HANDLING POTE NTI A L S4 OOO efm i PlAlC OUTS 80E CONTAMINATION 3

AIR AREA PER UNIT A UNILf AR Y PER NT SUILDING LEGENO S

LY P PREFILTER A H FFI E V AUXILIARY BUILDING SYSTEM (SHARED)

,IGp

(

E MER C CHARCOAL ADSORBER FIGURE Bl.0-2.

GASEOUS WASTE DISPOSAL AND VENTILATION SYSTEM l

(1 of 1) i t

i I

l

---.~.a--.-c.

-.~.

~ e a

a 1

i i

i Gland leak-off steam, which represents a minor source of activity, is route'd to the gland condenser. The non-condensable gases are passed through a vent stack to the roof; the condensables are condensed and drained to the i

condensate storage tank.

i b

I i

l i

4 i

t 5

4 i

i i

.)

l J

4 f

i b

4 4

4 f

i B-3 f

f

~

TABLE Bl.0-1 (1 of 2)

ABBREVIATIONS Systems:

KC - Component Cooling NB - Boron Recycle NC - Reactor Coolant ND - Residual Heat Removal NI - Safety Injection NR - Boron Thermal Regeneration NV - Chemical Volume and Control WC - Conventional Waste Water Treatment WG - Waste Gas WL - Liquid Waste Recycle WM - Liquid Waste Monitor and Disposal WS - Nuclear Solid Waste Disposal Te rms :

BOL - Beginning of Core Life BTRS - Boron Thermal Regeneration System CCW - Condenser Cooling Water CDT - Chemical Drain Tank ECST - Evaporator Concentrates Storage Tank EOL - End of Core Life FDT - Floor Drain Tank FWST - Fueling Water Storage Tank (formerly Refueling Water Storage Tank)

LHST - Laundry and Hot Shower Tank MST - Mixing and Settling Tank NCDT - Reactor Coolant Drain Tank RBT - Resin Batching Tank RHT - Recycle Holdup Tank RMT - Recycle Monitor Tank l

RMWST - Reactor Makeup Water Storage Tank TABLE Bl.0-1 (1 of 2)

- -=_

j..

t-TABLE Bl.0-1 (2 of 2) 5 ABBREVIATIONS l

SRST.- Spent Resin Storage Tank VUCDT - Ventilation Unit Condensate Drain Tank WDT - Waste Drain Tank WEFT - Waste Evaporator Feed Tank WMT - Waste Monitor Tank i

i i

a i

)

r TABLE Bl.0-1 (2 of 2)

L

i B2.0 RELEASE RATE CALCULATION Generic release rate calculations are presented in Section 1.0; these calculations will be used to calculate release rates for McGuire Nuclear Station.

B2.1 LIQUID RELEASE RATE CALCULATIONS There are three potential release points at McGuire. Two of these release points, the waste liquid effluent line and the containment ventilation unit condensate effluent line, discharge into the condenser cooling water flow; the third possible release point is through the conventional waste water treatment system.

B2.1.1 Waste Liquid Effluent Line To simplify calculations for the waste liquid effluent line, it is assumed that no activity above background is present in the containment ventilation unit condensate effluent. This assumption shall be confirmed by radiation monitoring measurements and by periodic analysis of the composite sample collected on that line. For the waste liquid effluent line, one of the follow-ing calculations shall be performed for discharge flow, in gpm, depending on the number of condenser cooling water pumps in service:

a n

ft 5 2.5E5+2.5(I Ci ) i 1.0E5+(I Ci )

i=1 MPC.

1 1

n a

f2 $ 5.0E5+2.5(I Ci ) $ 2.0ES+(I Ci )

i=1 MPC.

1 1

a a

f3 5 7.5ES+2.5(I Ci ) $ 3.0E5+(I Ci )

i=1 MPC.

1 1

n a

f $ 1.0E6+2.5(I Ci ) $ 4.0E5+(I Ci )

4 i=1 MPC.

i=1 MPC.

1 1

where:

C.

= the concentration of radionuclide, i, in undiluted effluent as 1

determined by laboratory analyses, in pCi/ml.

MPC the concentration of radionuclide, i, from 10CFR20, Appendix B, Table II, f = Column 2.

If radionuclide, i, is a dissolved noble gas, the MPC.,

= 2E-4pCi/ml.

F

= the dilution flow available depending on the number of condenser cooling water pumps in service, in gpm:

B-4

F

= 2.5E5 gpm t

T2

= 5.0E5 gpm F3

= 7.5E5 gpm F

= 1.0E6 gpm 4

a

= the recirculation factor at equilibrium is 2.5.

B2.1.2 Containment Ventilation Unit Condensate Effluent Line As described in the preceding section, it is possible but unlikely that the containment ventilation unit condensate effluent line will contain measurable activity above background; it is assumed that no activity is present in the effluent until indicated by radiation monitoring measurements and by periodic analysis of the composite sample collected on that line.

If measurable activity is present in the effluent, administrative controls shall be imple-mented to assure that release limits are not exceeded. See section on radia-tion monitoring alarm / trip setpoints.

B2.1.3 Conventional Waste Water Treatment System Effluent Line The conventional waste water treatment system effluent is normally considered nonradioactive; that is, it is unlikely the effluent will contain measurable activity above background.

It is assumed that no activity is present in the effluent until indicated by radiation monitoring measurements and by periodic analyses of the composite sample collected on that line. Radiation monitoring alarm / trip setpoints assure that release limits are not exceeded; see section on radiation menitoring alarm / trip setpoints.

B2.2 GASEOUS RELEASE RATE CALCULATIONS The unit vent is the release point for waste gas decay tanks, containment building purges, the condenser air ejector, and auxiliary building ventilation.

The condenser air ejector effluent is normally considered nonradioactive; that is, it is unlikely the effluent will contain measurable activity above back-ground.

It is assumed that no activity is present in the effluent until indicated by radiation monitoring measurements and by analyses of periodic samples collected on that line. Radiation monitoring alarm / trip setpoints in conjunction with administrative controls assure that release limits are not exceeded; see section on radiation monitoring setpoints.

The following calculations, when solved for flowrate, are the release rates for noble gases and for radioiodines, particulates and other radionuclides with half-lives greater than 8 days; the most conservative of release rates calculated in B2.2.1 and B2.2.2 shall control the release rate for a single release point.

B2.2.1 Noble Gases s

l IK

[(x/Q)Q ]

< 500 mrem /yr, and g

1 B-5

I (Lg + 1.1 M )

[(X/Q)Q ] < 3000 mrem /yr g

g i

where the terms are defined below.

B2.2.2 3adioiodines, Particulates, and Others s

IPg [W Q ] < 1500 mrem /yr g

1 where:

K

= The total body doese factor due to gamma emissions for each identified g

3 noble gas radionuclide, in mrem /yr per pCi/m from Table 1.2-1.

L

= The skin dose factor due to beta emissions for each identified noble 3 from Table 1.2-1.

gas radionuclide, in mrem /yr per pCi/m M.

= The air dose factor due to gamma emissions for each identified noble 3

gas radionuclide, in mrad /yr per pCi/m from Table 1.2-1 (unit conver-sion constant of 1.1 arem/arad converts air dose to skin dose).

P.

= The dose parameter for radionuclides other than noble gases for the 3

inhalation pathway, in mrem /yr per pCi/m and for the food and ground 2

plane pathways in m.(mrem /yr) per pCi/sec from Table 1.2-2.

The dose factors are based on the critical individual organ and most restrictive age group (child or infant).

Q *.

= The release rate of radionuclides, i, in gaseous effluent from all release points at the site, in pCi/sec.

3 (X/Q) = 2.6E-6 sec/m. The highest calculated annual average relative concen-tration for any area at or beyond the unrestricted area boundary.

W

= The highest calculated annual average dispersion parameter for estimating the dose to an individual at the controlling location:

3 W = 7.6E-8 sec/m, for the inhalation pathway. The location is the unrestricted area in the SW sector.

W = 2.0E-8 meter 2, for the f,ad and ground plane pathways. The location is the unrestricted area boundary in the E sector (nearest residence, cow, and vegetable garden).

s Q.

= k C.f + k2 = 4.72E+2C.f t

1 1

1 where:

C.

= the concentration of radionuclide, i, in undiluted gaseous effluent, in pCi/ml.

f

= the undiluted effluent flow, in efm B-6

3 k

= conversion factor, 2.83E4 ml/ft t

k

= conversion factor, 6El sec/ min 2

i l

B-7

B3.0 RADIATION MONITOR SETPOINTS Using the generic calculations presented in Section 2.0, radiation monitoring setpoints are calculated for monitoring required by the Technical Specifications.

B3.1 LIQUID RADIATION MONITORS B3.1.1 Waste Liquid Effluent Line As described in Section B2.1.1 on release rate calculations for the waste liquid effluent, the release is controlled by limiting the flow rate of effluent from the station. Although the release rate is flow rate controlled, the radiation monitor setpoint shall be set to L rminate the release if the effluent activity should exceed that determined by laboratory analyses and that used to calculate the release rate.

B3.1.2 Containment Ventilation Unit Condensate Effluent Line As described in Section B2.1.2 on release rate calculations for the containment ventilation unit condensate effluent, it is possible but unlikely that the effluent will contain measurable activity above background.

It is assumed that no activity is present in the effluent until indicated by radiation monitoring and by routine analyses of the composite sample collected on that line. Since the tank contents are discharged automatically, a maximum tank concentration, which also is the radiation monitor setpoint, is calculated to assure that release limits are not exceeded. The monitor setpoint and maximum tank concen-tration is:

xF c1 1 1.25E-4 pct /ml gg where:

'c

=t gross activity in undiluted effluent, in pCi/ml f

= the flow from the tank may vary from 0-100 gpm but, for this calcula-tion, is assumed to be 100 gpm CrMPC = IE-7 pCi/ml, the MPC for an unidentified mixture o

=2 F

= the dilution flow may vary as described in B2.1.1, but is conservatively estimated at 2.5E+5 gpm, the minimum flow available The above calculation determines the maximum setpoint for this release point; releases and/or setpoints may be administratively controlled to assure that release limits are not exceeded since more than one release source may be released to the condenser cooling water.

B3.1.3 Conventional Waste Water Treatment System Discharge Line As described in Section B2.1.3 on release rate calculations for the conventional waste water treatment system effluent, the effluent is normally considered B-8

non-radioactive; that is, it is unlikely the effluent will contain measurable activity above background.

It is assumed that no activity is present in the effluent until indicated by radiation monitoring and by routein analysis of the composite sample collected on that line. Since the system discharges auto-matically, the maximum system concentration, which also is the radiation moni-tor setpoint, is calculated to assure compliance with 3.11.1.1.

The monitor setpoint and maximum effluent concentration is:

x F < 3.6E-5 pCi/ml c<

g where:

c

= the gross activity in undiluted effluent, in pCi/ml f

= the flow rate of undiluted effluent which may vary from 0-600 gpm, but is assumed to be 600 gpm C=MPC = IE-7 pCi/ml, the MPC for an unidentified mixture o

=1 F

= the flow may vary from 80 to 50,000 cfs, but is conservatively esti-mated at 80 cfs (3.6E+4 gpm), the minimum flow available D3.2 GAS MONITORS As stated in Section B2.2, the unit vent is the release point for waste gas decay tanks, containment building purges, the condenser air ejector, and auxi-11ary building ventilation. Since all of these releases are through the unit vent, the radiation monitor on the unit vent may be used to assure that station release limits are not exceeded. Depending on the stack flow, the radiation monitor setpoint may be:

C < 1.29E+3/f <

1.6E-2 pCi/ml where:

f = 54,000 cfm (auxiliary building) + 28,000 cfm (containment purge) = 82,000 cfm or may be:

C < 1.29E+3/f <

2.4E-1 pCi/mi where:

F = 54,000 cfm (auxiliary building ventilation)

B-9 i

l A

B4.0 DOSE CALCULATIONS B4.1 FREQUENCY OF CALCULATIONS Dose contributions to the maximum exposed individual shall be calculated quarterly, semiannually, and annually (as required by Technical Specifications) using the methodology in the generic information sections. This methodology shall also be used for any special reports. Dose projections and dose calcula-tions for time periods less than a quarter shall be performed using simplified estimates. Fuel cycle and population does calculations shall be performed annually or as required by special reports. Dose contributions shall be calcu-lated using the methodology in the appropriate generic information sections.

B4.2 DOSE MODELS FOR MAXIMUM EXPOSED INDIVIDUAL B4.2.1 Liquid Effluents For liquid radioactive efflaent release, it is assumed that the maximum exposed individual is an adult who consumes fish caught in the discharge area and drinks water from the nearest " downstream" water supply.

B4.2.2 Gaseous Effluents B4.2.2.1 Noble Gases For dose contributions from exposure to beta and gamma radiation from noble gases, it is assumed that the maximum exposed individual is an adult on the site boundary in each meteorological sectors.

B4.2.2.2 Radioiodines, Partin:lates, and Other Nuclides For dose contributions from radioiodines, particulates and other radionuclides; it is assumed that the maximum exposed individual is an infant who breathes the air and consumes milk from the nearest goat or cow in each meteorological sector.

B4.3 SIMPLIFIED DOSE ESTIMATE B4.3.1 Liquid Effluents For dose calculations for tine periods less than a quarter, simplified dose estimates using the assumptions presented in Section B4.2.2 and source terms presented in the FSAR are presented below. Dose calculations used to evaluate Appendix I to 10 CFR50 compliance indicate that the maximum exposed individual is an adult who consumes fish caught in the discharge area and that 90% of the dose is from cesium-134 and cesium-137.

I m

D

( Cs-134 + 0.59 CCs-137)

WB 1=1 B-10 T

where:

i U

6.64E5 = (1.10)(1.14E5) g*E + 21 BF DF and all terms are as previously g

g W

defined except the following:

CCs-134 = the average concentration of Cs-134 in undiluted effluent, in pCi/ml, during the time period considered.

C the average concentration of Cs-137 in undiluted effluent, in pCi/ml, Cs-137 = during the time period considered.

Dy = dilution factor from the near field area to the potable water intake, 0.42.

B4.3.2 Gaseous Effluents Meteorological data is provided in Tables B4.0-1 and B4.0-2.

B4.3.2.1 Noble Gases For dose calculations for time periods less than a quarter, simplified dose estimates using the assumptions in B4.2.2.1 and source terms in the FSAR are presented below. These calculations further assume that the annual average dispersion paraseter is used and that xenon-133 contributes 45% of the dose.

s D = 6.96E-11 [Q]Xe-133 s

g = 2.07E-10 [QJXe-133 D

where:

3 X/Q

= 2.8E-6 sec/m s

6.96E-11 = constant determined from factors previously presented 2.07E-10 = constant determined from factors previously presented s

[Q]Xe-133 = the total xenon-133 activity released in pCi B4.3.2.2 Radioiodines, Particulates, and Other Nuclides For dese calculations for time periods less than a quarter, simplified dose estimates using the assumptions in B4.2.2.2 and source terms in the FSAR are presented below. These calculations further assume that the annual average dispersion / deposition parameter is used and that 95% of the dose is from iodine-131 concentrated in goat's milk. The simplified dose estimate to the thyroid of an infant is:

s D = 1.75ES w (Q)I-131 where:

2 from Table B4.0-2 for

= D/Q for food and ground plane pathway, i' m w

location of nearest real cow or goat.

r s

(Q)I-131 = the release of iodine-131 in gaseous effluents, in pCi.

B-11

^

i i

1.75E+5 = (.05(3.17E-8) R [D/Q] with the appropriate substitutions in a

R [D/Q] for iodine-131. See Section B3.1.2.

B4.3 FUEL CYCLE CALCULATIONS i

These calculations shall be performed using models presented in Section 3.3.

B4.4 POPULATION DOSES TO BE SUPPLIED LATER.

t i

1 i

a

'l 1

4 l

l l

1 5

1

]

~

I a

f B-12

- ~

,,g.

TABLE B4.0-1 (1 of 1)

MCGUIRE NUCLEAR STATION DISPERSION PARAMETER (X[(j) FOR LONG TERM RELEASES > 500 HR/YR OR > 125 HR/QTR Distance to the control location, in miles Sectar 0 0-0.5*

0.5-1.0 1.0-1.5 1.5-2.0 2.0-2.5 2.5-3.0 3.0-3.5 3.5-4.0 4.0-4.5 4.5-5.0 N

1.2E-6 5.2E-7 2.7E-7 1.7E-7 1.2E-7 9.0E-8 7.0E-8 6.lE-8 4.8E-8 NNE 2.3E-6 1.0E-6 5.7E-7 3.6E-7 2.4E-7 2.0E-7 1.4E-7 1.2E-7 9.6E-8 NE 2.3E-6 1.0E-6 5.5E-7 2.9E-7 2.3E-7 1.7E-7 1.2E-7 1.lE-7 9.2E-8 ENE 1.6E-6 6.7E-7 3.6E-7 2.2E-7 1.5E-7 1.0E-7 8.9E-8 8.0E-8 6.6E-8 g

hi E

1.lE-6 3.8E-7 2.1E-7 1.4E-7 9.0E-8 7.8E-8 6.lE-8 5.3E-8 4.0E-8

[

ESE 9.6E-7 3.8E-7 1.8E-7 1.2E-7 8.4E-8 5.5E-8 4.3E-8 4.1E-8 3.4E-8 o

g; -

SE 1.0E-6 4.lE-7 1.7E-7 1.lE-7 8.lE-8 5.7E-8 4.6E-8 4.lE-8 3.3E-8

?

SSE 1.lE-6 4.4E-7 1.9E-7 1.2E-7 8.3E-8 6.0E-8 5.4E-8 4.8E-8 3.7E-8 S

1.2E-6 5.2E-7 2.7E-7 1.7E-7 1.3E-7 9.0E-8 6.5E-8 6.5E-8 5.2E-8 SSW 2.3E-6 9.0E-7 4.2E-7 2.6E-7 1.8E-7 1.2E-7 9.4E-8 8.3E-8 6.6E-8 SW 2.6E-6 9.3E-7 4.2E-7 2.4E-7 1.7E-7 1.lE-7 9.5E-8 8.6E-8 7.0E-8 WSW l.6E-6 5.8E-7 2.7E-7 1.5E-7 9.8E-8 6.6E-8 5.5E-8 4.8E-8 3.7E-8 W

l.0E-6 3.8E-7 2.0E-7 1.2E-7 8.6E-8 6.2E-8 5.0E-8 4.3E-8 3.3E-8 WNW 6.8E-7 2.6E-7 1.6E-7 1.0E-7 6.9E-8 5.lE-8 4.2E-8 3.7E-8 3.0E-8 NW 6.4E-7 2.9E-7 1.6E-7 1.lE-7 7.4E-8 5.3E-8 4.7E-8 4.2E-8 3.4E-8 NNW 8.0E-7 3.8E-7 2.lE-7 1.3E-7 8.4E-8 7.2E-8 5.9E-8 5.4E-8 4.4E-8

Inside EAB

TABLE B4.0-2 (1 of 1)

MCGUIRE NUCLEAR STATION DEPOSITION PARAMETER (D/Q) FOR LONG TERM RELEASES > 5001[R/YR OR > 125 IIR/QTR Distance to the control location, in miles Sector 0 0-0.5*

0.5-1.0 1.0-1.5 1.5-2.0 2.0-2.5 2.5-3.0 3.0-3.5 3.5-4.0 4.0-4.5 4.5-5.0 N

2.2E-8 5.8E-9 2.3E-9 1.1E-9 6.5E-10 4.0E-10 2.9E-10 2.4E-10

? 8E-10 NNE 4.8E-8 1.3E-8 5.0E-9 2.4E-9 1.5E-9 9.0E-10 6.4E-10 5.4E-10 4.0E-10 NE 5.2E-8 1.6E-8 5.7E-9 2.6E-9 1.7E-9 1.0E-9 7.0E-10 5.9E-10 4.4E-10 ENE 2.2E-8 6.1E-9 2.3E-9 1.lE-9 6.8E-10 4.2E-10 3.0E-10 2.5E-10 1.9E-10 g

2

p E

1.6E-8 4.9E-9 2.0E-9 9.0E-10 5.6E-10 3.4E-10 2.4E-10 2.0E-10 1.5E-10 o[

ESE 1.9E-8 4.6E-9 1.8E-9 8.5E-10 5.lE-10 3.1E-10 2.3E-10 1.9E-10 1.4E-10 SE 3/2E-8 8.lE-0 3.2E-9 1.4E-9 8.9E-10 5.5E-10 3.8E-10 3.2E-10 2.4E-10

9 N

SSE 2.8E-8 7.0E-9 2.7E-9 1.2E-9 7.5E-10 4.6E-10 3.2E-10 2.8E-10 2.lE-10 S

3.9E-8 9.9E-9 3.8E-9 1.7E-9 1.1E-9 6.6E-10 4.7E-10 4.0E-10 3.0E-10 SSW 5.6E-8 1.4E-8 5.5E-9 2.4E-9 1.5E-9 9.4E-10 6.6E-10 5.6E-10 4.3E-10 SW 7.6E-8 1.8E-8 6.9E-9 3.lE-9 2.0E-9 1.2E-9 8.3E-10 7.1E-10 5.3E-10 WSW 3.lE-8 1.3E-9 2.9E-9 1.3E-9 8.0E-10 4.8-10 3.5E-10 3.0E-10 2.2E-10 W

2.4E-8 5.8E-9 2.3E-9 1.0E-9 6.3E-10 3.9E-10 2.8E-10 2.4E-10 1.8E-10 WNW l.3L-8 3.2E-9 1.2E-9 5.6E-10 3.5E-10 2.1E-10 1.6E-10 1.3E-10 9.6E-Il NW 1.6E-8 4.lE-9 1.6E-9 7.3E-10 4.5E-10 2.7E-10 2.0E-10 1.7E-10 1.2E-10 NNW l.8E-i 4.6E-9 1.8E-9 8.3E-10 5.lE-10 3.1E-10 2.3E-10 1.9E-10 1.4E-10

Inside EAll

~

B5.0 RADIOLOGICAL ENVIFONMENTAL MONITORING The radiological environmental monitoring program shall be conducted in accor-dance with Technical Specification 3/4.12. The monitoring program locations and analyses are given in Tables B5.0-1 through B5.0-3 and Figure B5.0-1 Site specific characteristics make groundwater sampling, special low level I-131 analyses on drinking water, and food product sampling unnecessary. Groundwater recharge is from precipitation and the groundwater gradient is toward the effluent discharge area; therefore, contamination of groundwater from liquid effluents is highly improbable. Special low level I-131 analyses in drinking water will not be performed routinely since the expected I-131 dose from this pathway is less than 1 mrem / year. Food products will not be sampled since lake water irrigation of crops is not practiced in the vicinity. Additionally, two site boundary TLD locations in the NW and NNW sectors do not exist since the required locations are over water.

The laboratory performing the radiological environmental analyses shall parti-cipate in an interlaboratory comparison program which has been approved by the NRC.

B-13

1 5

TABI.E 85.0-l i

(I of I)

I MsGUlkE RADIOIDGICAl. ft;NITOkiNG PhoGkAN SAMPLING LOCATIONS 4

(Tlh IDCATIONS) i SAMPLING 1AWAllON DESfkiPTION

SAMPLING IMCATION DESCkirTION

4 5 Mile liADillS (5.'OlllT5S SE) 7~

~

[20'~ ~ SITE lkilNNhkY (075 Mlil5'N) 140

~

~~

121 SITE lH41NDANY (0.7 HILES NNE) 141 4-5 MllI kAllius (4.5 HlilS ESE) 122 SITE IMMINDARY (0.5 HILEI NE) 142 4-5 HILE MADIUS (5.0 MilM' S) 123 SITE INRJNDANY (0.5 Hil18 ENE) 143 4-5 Hill BADIUS (5.2 HIL.48 SSW) 124 Si1E BOUNDAitY (0.5 Mllf! E) 144 4-5 Mill RADIllS (4.9 Mills 3W) 125 SITE IM)UNDANY (0.5 HILJ $ ESE) 145 4-5 Hill kADIUS (4.7 HILES 'mSW) 12I.

SITE IWdlNDARY (0.6 MilJS SE) 146 4-5 MIII RADillS 4.4 Hills W) 121 SITE IMAINDARY (0.5 HI!JS SSE) 147 4-5 Mill RApills (4.4 MllES WWW) 42n SITE lifdlNDANY (0.5 MilJS 3) 148 4-5 MIII kADIUS (4.5 Hills NW) 129 SITE IWHINDAkY (0.5 MllAS SSW) 149 4-5 Mile RAllIUS (5.2 HIIIS NWW) 130 SITE IWMINDARY (0.5 HIIES SW) 150 SPECIAL INTEkEST (8.5 Hills N)

N 131 SITE IKNINilAkY (0.7 HILES WSW) 151 SPECIAL INTEkEST (17.5 HilES NE)

Oh 1 52 SITE BullNDARY (0.7 MILES W) 152 SPEC!*! I m ysst G.5 MILES NE) o 133 SITE bOUNDANY (0.5 MILES WNW) 153 SPECIAL INTEREST (6.2 MilIS ENE)

O 114 4-5 Mill kADillS (4.8 MllI3 N) 154 SPECIAL INTEkEST (10.8 MllIS ESE)

Oh I 15 4-5 Mill NADillS (4.4 MiliS NNE) 155 SPECIAL INTEkEST (5.9 HII13 S)

I lb 4-5 HilE MADIUS (5.0 MilIS NE) 156 SPECIAL INTEREST (10.8 NilIS SW)

Ill 4-5 Mill NADIUS (4.9 Mllj.S ENEl 157 CONTeot (12.2 MiliS SSE)

I 18 4-5 MIII kADIUS (4.7 MILES E) 158 CONThol (8.9 Hills S)

I 'l'A 4-5 NIIE RADillS (4.6 miles ESE) 159 CON 1kOL

_ {S. 7 WilS WSW} __

a All Tlu. plc.,,,coggng,a,,,,,,,,g, s

c@@

5@

2EY

a 1

F*

TABLE B5.0-2 (1 of l)

MCCu!HE kAD10uMICAL thWITONING l'kOGRAM SAMPLING DEATIONS (UTHEN SAMPLING UKATIuleS)

C40Es W - Weekly y - Quaaterly l*

SN - Semimonthly SA - Semiannual

]'

ti - Nuthly gm j

5 g

i U

d o

m d

6 k

M

-t e

m g

n

.______~.1_____..,

.g g

g y

Ul 5

2 w

-SAPIPLING LOCAT1014 IESJIPUDIA sin a

en P

Site BuuuJary (0.1 miles NNE)

W

~

laat(,.

161 Site boundary'(0.5 miles NE)

W 162 Site Boundary,le.5 mitet SW)

,W M

g

_~

I63 Dis hjrge Canal DrsJge'(0.4 efles LNE)

H en l

Ib4 Distliasse Canal Edt rance tu 1.ake Nosman (0.6 miles ENE)

SA SA k

n.

~ ?,

10 liwy. 13 tsridge !)ownst ream (0.6 miles SW)

M SA e

-8 6t, Huntcasvil,le Municipal Water Supply (3.0 miles ENE)

M y_.

. l41 Charlotte Mus.icipal Water Supply (ll.2 miles SSE)

M.

I t.8 Cusuelius (6.2 miles hE)

W 169 East Linculu Junior H 4h School (8.7 miles WNW)

Control W

M

{

,}

h y

170 Pl.ut Marshall lutake Canal (12.0 miles N)

Control N

ili Nasesville muscapal Water Sul. ply (12.5 uf l.es NNE) Control M

112 l

Asea (12.0 miles N)

Cuatrol SA

' SA j

_.. _'inuat' l e Acc ess. - _ _ _ _. _ _. _ _..

j 17i Anibard Daisy (I.8 miles ESE) - Cows SM t/4 NC liowell Hesidense (I.8 miles SSE) - Goats hN b

4/5 Ashi Dassy (4.6 miles SSE) - Cow.

SM I/h 6ceves Ita s ty 17. 3 a.iles NW) - Cows Contrul SN c-._-..__._

, f//

Davidson Nus(& pal Water Supply (7.5 miles NE)

M b,.,...

f

4 M

]

I TAh!.E 85.0-3 (i ut 1)

NAuf kE kAD1011MICAL th)NIToklNG Pk(6kAM ANALYSES ANALYSES SAHl'Il Mk uillN ANALYSIS SCllEIMilE CAMMA ISOTOPIC TkITitti 11M l.EVEL I-111 GkuSS hk.1A TfD I.

Aar kadiosodine and Partatulates Weekly X

2.

11a s et t Medantavu Quarterly g

1.

Sustate Water Monthly X

Quarterly Composite X

4.

lir anhang W4ter Huntialy X

X Quarterly Composite X

t 5.

Sisuselane Sedament Semiannually X

,D

c. N w

t,. Naik Seminanthly X

X p

1.

Fi hte Semiannually X

M.

Mana.lleal Vesttelion Honthly X

L3 FD EE8 0

D k@

f' r

CA, )

A cc

-- l.

y

,%m\\tkil\\f!i.- l,

-= w "c,

. \\u,m L g

s.

w-8 l *$r...h ' !'.

f

}

.){

\\

\\.

,s.,

f

_ h

a. ; N, ts h(W d6.s

-}

3 j

1 v

m--

_w

~~

je g <&g -

i

?,,,

-Y 92

)w 4

q g,,

r-t t :, e j.

i,

.\\

\\,j s

i

. ~

.N, k.,i

g P 3

{\\&A.

b 4B' Y s

'l]jg, kh

' 3 ' SK. C f k ). h y

f,,.'"",,%-s,-

% 1 '.. #!i,;[gj(-Mf%.wgQQ "dy, m'o u

~' N

..[ "2'p,,;'N - m \\a,)t N..a w ps i

,e s

.(

g m

/,

s.

,,,.n

.. - \\

V#

.,. \\'

Wy,,,.

- % = 3,, : : g, y [ s i

'. 'l.,fe[.C,N'I,h

,i3,(9/

iu n.,

c

.t na

. ~

=

m

+.

8 uy yg v

y

.,.., !~p.,.

,,,; L' ( gy y;p

'A l

/3g4/

j 1

m T 'pw/ r4'4T y yf- -

g/ j -\\ \\w,# w' I4 Q4 5'"^

f Qg g-

. (

~ (

-. g-f t*"

2 n

%(

~,

3 et v

~.

w f

I

,,,, !nf - (J '1k,\\Q

,e w,

g _c 2

# r.** 'q i

I swa j%.?

2

.7 f

x_..(. )N

[ %,\\ m\\ gh

\\

f

,.,,,...m-f

... m, s gh&(

p 7 ('

- I f,$ l~,. kj]/ g<4,.4 % w?Mg&

y%

x s..

,J "" y.

x MG's.m

'N

/~^

y m\\

..N T

% e* m 'N, ($ g

' )

s

~

)g.

s.fQ N

r 1

'** h Qf

?%

,.\\ ~g g Y r, '~Y O

g;~ g%" n \\:y,.(

,(

r' Cm 1

4";

g s

g@m Qbg,,

&p... m [.- x> /

,~ < R ; Q.

O;pa :

D,. J,,%n

.s r

... o > =

vO 3NII L.E.

db,

- pb,

i sm-s u

hm 4' '*'V '"L i b. b b h k *> M A > f. d "",,

N IM u

9 ;n i

_,.g,';s.;s.,g/

e s

.,..y I,

M

gk gS am s,e

>,,L

+c

k. h M

's I(-

+,

\\

o n

o e W

g 24 I

~

g 4 w<- p.

%k,ye m "-

a s.- ;". y - -

a.

ss2 9.

e. s

,M; #

.. s.,

r

=

a g. M d' s

... X?

e-g "XN

re-S gp

$6 f

g,<.,

S s

+

~

EXCLUSION AREA "j?q' g

. izO - iss I'fN. D' A 160 - 164, 168 r

f

-l t

~y

\\

s.?k*

. u) ighep,-

f 4

OTLD LOCATIONS g

.g,, ', *\\

. 'N y

*x (3

A ALL OTHER LOCATIONS a [Q *D '_ SS?

4 s

s s i

(

k N

.i4 f.,

1 (k [kIf

=

,1 e.4

\\ 4sg

,,* ?

4 -

w t

l\\

MONITORING PROGRAM LOCATIONS f

d.s r' FIGURE B5.0-1

~ 7 I

g (1 of 1) 4 A

Td

'

ML19305B803

Text

.=

Navigation menu

Search